Sentence,class,file
"http://dx.doi.org/10   .1016/j.molcel.2011.12.02 8 Yeo, J.E., E.H. Lee, E.A.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1093/hmg/ddu07 8 Yin, J., Y.T.",OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1093/hmg/ddh26 9 Ying, S., F.C.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-11-341 7 Zellweger, R., D. Dalcher, K. Mutreja, R. Herrador, M. Berti, A. Vindigni, and M.  Lopes.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
"http://dx.doi.org/10.1038/ncb289 7 Zhu, Z., W.H.",Non-OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
http://dx.doi.org/10.1016/j.cell.2008.08.03 7,OADS,/arxiv_data1/oa_pdf/94/3f/JCB_201406100.PMC4347643.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/   jbc.M111.25044 9 Ahmed, K., S. Tunaru, C. Tang, M. Müller, A. Gille, A. Sassmann, J. Hanson,  and S. Offermanns.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"11:311– 319. http://dx.doi.org/10.1016/j.cmet.2010.02.01 2 Alligier, M., E. Meugnier, C. Debard, S. Lambert-Porcheron, E. Chanseaume,  M. Sothier, E. Loizon, A.A. Hssain, J. Brozek, J.Y.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1210/jc.2011-231 4 Amole, B.O., M. Wittner, D. Hewlett, and H.B.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2174/13816121179690473 1 Ariotti, N., S. Murphy, N.A.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1091/mbc.E11-10-084 7 Asterholm, I.W., D.I.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2012.01.00 4 Asterholm, I.W., J.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1007/s00125-014-3210- 3 Barbarroja, N., S. Rodriguez-Cuenca, H. Nygren, A. Camargo, A. Pirraco,   J. Relat, I. Cuadrado, V. Pellegrinelli, G. Medina-Gomez, C. Lopez- Pedrera, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/db14-035 9 Bikman, B.T., Y. Guan, G. Shui, M.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M112.35995 0 Blachnio-Zabielska, A.U., C. Koutsari, T. Tchkonia, and M.D.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1002/jcp.2274 5 Blüher, M. 2014.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.molmet   .2014.01.00 5 Blüher, M., M.D.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/S1534-5807(02)00199- 5 Bolten, C.W., P.M. Blanner, W.G.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1074/jbc.M40934020 0 Cao, H. 2014.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1530/JOE-13-033 9 Caspar-Bauguil, S., B. Cousin, S. Bour, L. Casteilla, L. Penicaud, and C. Carpéné.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"67:497) http://dx.doi.org/10.1007/BF0318593 8 Cho, Y .M., D.H. Kim, S.N.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.febslet.2013.04.00 5(Sun et al., 2013a).",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"409:729– 733. http://dx.doi.org/10.1038/3505557 5 Agarwal, A.K., and A. Garg.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
http://dx.doi.org/10.1016/S1043-2760(03)00078- X,OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1152/ajpendo.00527.201 1 Furukawa, S., T. Fujita, M. Shimabukuro, M. Iwaki, Y. Yamada, Y. Nakajima,  O. Nakayama, M. Makishima, M. Matsuda, and I. Shimomura.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1172/JCI2162 5 Gao, C.L., C. Zhu, Y.P.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/   j.mce.2010.01.03 9 Garg, A.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1210/jc.2011-115 9 Gburcik, V., W.P.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1074/jbc.272.28.1768 6 Guan, H.P., Y. Li, M.V.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/nm78 0 Gupta, R.K., R.J. Mepani, S. Kleiner, J.C.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"15:230– 239. http://dx.doi.org/10.1016/j.cmet.2012.01.01 0 Hage Hassan, R., O. Bourron, and E. Hajduch.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"5:244– 257. http://dx.doi.org/10.4239/wjd.v5.i3.24 4 Halberg, N., T. Khan, M.E.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1007/s00125-012-2809- 5 Hao, Q., J.B. Hansen, R.K. Petersen, P. Hallenborg, C. Jørgensen, S. Cinti, P.J.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.bbalip.2009.11.00 8 Hapala, I., E. Marza, and T. Ferreira.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"103:271– 285. http://dx.doi.org/10.1042/BC2010014 4 Henegar, C., J. Tordjman, V .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1186/gb-2008-9-1-r1 4 Herman, M.A., O.D.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1126/   science.124907 7 Holland, W.L., and S.A. Summers.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1210/   er.2007-002 5 Holland, W.L., J.T.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2007.01.00 2Choi, S.M., D.F.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"30:5009– 5020. http://dx.doi.org/10.1128/MCB.00797-1 0 Choi, K.M., Y .S.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1248/bpb.34.91 2 Choo, H.J., J.H.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/db10-007 3 Coburn, C.T., F.F.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M00382620 0 Cohen, A.W., B. Razani, X.B.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1152/   ajpcell.00006.200 3 Cohen, A.W., B. Razani, W. Schubert, T.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/diabetes.53.5.126 1 Combs, T.P., S. Nagajyothi, S. Mukherjee, C.J.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/diabetes.53.5.124 3 Davis, K.E., M. D Neinast, K. Sun, W. M Skiles, J.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.molmet.2013.05.00 6 Deng, Y ., and P.E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"287:6240– 6249. http://dx.doi.org/10.1074/jbc.M111.29911 5 Digel, M., R. Ehehalt, and J. Füllekrug.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.febslet.2010.03.03 5 Ding, S.Y ., M.J. Lee, R. Summer, L. Liu, S.K.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M113.54624 2 Feldmann, H.M., V .",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.cmet.2008.12.01 4 Ferreira, A.V ., M. Segatto, Z. Menezes, A.M. Macedo, C. Gelape, L. de Oliveira  Andrade, F. Nagajyothi, P.E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.micinf.2011.06.00 2 Festuccia, W.T., P.G.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1152/ajpregu.91012.200 8 Forest, C., J. Tordjman, M. Glorian, E. Duplus, G. Chauvet, J. Quette, E.G.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1042/BST031112 5 Franckhauser, S., S. Muñoz, A. Pujol, A. Casellas, E. Riu, P. Otaegui, B. Su,  and F. Bosch.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
http://dx.doi.org/10.2337/diabetes.51.3.62 4,Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2012.03.00 9 Lee, Y.S., J.W.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j   .cell.2014.05.01 2 Levy, A., S. Enzer, N. Shoham, U. Zaretsky, and A. Gefen.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1007/s10439-011-0496- x Lim, J.H., H.J.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.cellsig.2008.10.00 4 Liu, L., D. Brown, M. McKee, N.K.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"8:310– 317. http://dx.doi.org/10.1016/j.cmet.2008.07.00 8 Lobo, S., B.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr   .M600441-JLR20 0 Long, J.Z., K.J.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/   j.cmet.2014.03.02 5 Lowe, C.E., R.J. Dennis, U. Obi, S. O’Rahilly, and J.J. Rochford.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/ijo.2011.23 3 Lu, R.H., H. Ji, Z.G.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1007/   s11033-009-9695- z MacLaren, R., W. Cui, and K. Cianflone.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1007/978-0-387-78952-1_ 1 Meshulam, T., M.R.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr.M01562 8 Millward, C.A., D. Desantis, C.W.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr.M00536 3 Mitsutake, S., T. Date, H. Yokota, M. Sugiura, T. Kohama, and Y .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1016/j.febslet.2012.03.03 2 Nagajyothi, F., M.S.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/oby.2008.33 1 Nagajyothi, F., D. Zhao, F.S.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1086/65618 9 Nagajyothi, F., L.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1371/journal.pntd.000095 3 Nagajyothi, F., F.S.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1111/j.1462-5822.2012   .01764. x Nagajyothi, F., R. Kuliawat, C.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/   j.ajpath.2012.11.02 7 Nallamshetty, S., S.Y.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.freeradbiomed.2013.05.02 2Holland, W.L., B.T.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1172/   JCI4337 8 Holland, W.L., R.A. Miller, Z.V.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/nm.227 7 Holland, W.L., A.C. Adams, J.T.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2013.03.01 9 Huh, J.Y., E.Y.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.3747/pdi.2009.0022 8 Jaworski, D.M., O. Sideleva, H.M. Stradecki, G.D. Langlois, A. Habibovic,  B. Satish, W.G.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1210/en.2010-102 9 Kahn, B.B., and S.W.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1002/   dmr.561001030 1 Keller, M.P., and A.D. Attie.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1146/annurev.nutr.012809.10474 7 Khan, T., E.S.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1128/MCB.01300-0 8 Kim, M., M.D.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j   .molmet.2014.05.00 7 Kleiner, S., R.J. Mepani, D. Laznik, L. Ye, M.J. Jurczak, F.R.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1073/pnas.120728710 9 Konige, M., H. Wang, and C. Sztalryd.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.bbadis   .2013.05.00 7 Koves, T.R., J.R. Ussher, R.C.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2007.10.01 3 Kusminski, C.M., and P.E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.tem.2012.06.00 4 Kusminski, C.M., W.L.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/nm.289 9 Lackey, D.E., D.H. Burk, M.R.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M80743820 0 Lass, A., R. Zimmermann, M. Oberer, and R. Zechner.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.plipres.2010.10.00 4 Le Lay, S., C.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
http://dx.doi.org/10.1016/j.bbalip.2008.10.00 8,OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/db13-106 7 Shan, D., J.L.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr.M00630 4 Shepherd, P.R., L. Gnudi, E. Tozzo, H. Yang, F. Leach, and B.B.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M20856320 0 Shoham, N., R. Gottlieb, O. Sharabani-Yosef, U. Zaretsky, D. Benayahu, and A.  Gefen.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1152/ajpcell.00167.201 1 Shoham, N., P. Girshovitz, R. Katzengold, N.T.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.bpj.2014.01.04 5 Spalding, K.L., E. Arner, P.O.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1074/jbc.C113.54475 9 Stöckli, J., D.J.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1242/jcs.09706 3 Sturley, S.L., and M.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1172/JCI4588 7 Sun, K., I. Wernstedt Asterholm, C.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1128/MCB   .00951-1 2 Sun, K., J. Tordjman, K. Clément, and P.E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/   j.cmet.2013.06.01 6 Takahashi, Y ., A. Shinoda, N. Furuya, E. Harada, N. Arimura, I. Ichi, Y .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1038/nm0703-81 1 Tanaka, N., S. Takahashi, T. Matsubara, C. Jiang, W. Sakamoto, T. Chanturiya,  R. Teng, O. Gavrilova, and F.J. Gonzalez.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1126/   science.115623 2 Tanowitz, H.B., B. Amole, D. Hewlett, and M. Wittner.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"82:90– 93. http://dx.doi.org/10.1016/0035-9203(88)90272- 6 Tansey, J.T., C. Sztalryd, J. Gruia-Gray, D.L.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.bbalip   .2013.01.00 9 Nedergaard, J., and B. Cannon.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/   j.cmet.2014.07.00 5 Nobusue, H., N. Onishi, T. Shimizu, E. Sugihara, Y. Oki, Y. Sumikawa, T.  Chiyoda, K. Akashi, H. Saya, and K. Kano.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"5:3368. http://dx.doi.org/10.1038/ncomms436 8 Okada-Iwabu, M., T. Yamauchi, M. Iwabu, T. Honma, K. Hamagami, K. Matsuda,  M. Yamaguchi, H. Tanabe, T. Kimura-Someya, M. Shirouzu, et al.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/nature1265 6 Orlicky, D.J., J. Monks, A.L.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1371/journal   .pone.006683 7 Pasarica, M., O.R.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.2337/db08-109 8 Pellegrinelli, V., J. Heuvingh, O. du Roure, C. Rouault, A. Devulder, C. Klein,  M. Lacasa, E. Clément, D. Lacasa, and K. Clément.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1002/path.434 7 Pérez-Matute, P., L. Pérez-Martínez, J.R. Blanco, and J.A.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M70740420 0 Razani, B., T.P.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M11097020 0 Regazzetti, C., F. Bost, Y .",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc.M109.04768 8 Reue, K., and J.R. Dwyer.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr.R800052-JLR20 0 Ring, A., S. Le Lay, J. Pohl, P. Verkade, and W. Stremmel.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.bbalip.2006.03.01 6 Rodeheffer, M.S., K. Birsoy, and J.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.09.03 6 Roh, C., R. Roduit, B. Thorens, S. Fried, and K.V .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/ jbc.M10279120 0 Samuel, V .T., Z.X.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1083/jcb.127.5.123 3 Seale, P., B. Bjork, W. Yang, S. Kajimura, S. Chin, S. Kuang, A. Scimè, S.  Devarakonda, H.M. Conroe, H. Erdjument-Bromage, et al.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"454:961– 967. http://dx.doi.org/10.1038/nature0718 2 Sha, H., Y .",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.cmet.2009.04.00 9 Sha, H., L. Yang, M. Liu, S. Xia, Y .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1152/ajpendo.00456.200 4 Ye, J., Z. Gao, J. Yin, and Q.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"3. http://dx.doi.org/10.7554/eLife.0385 1 Yuan, T., S. Hong, Y. Yao, and K. Liao.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1097/01.mol.0000169354.20395.1 c Zeve, D., W. Tang, and J. Graff.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.stem.2009.10.01 4Tordjman, J., G. Chauvet, J. Quette, E.G.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1074/jbc   .M20699920 0 Turpin, S.M., H.T.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1016/j.cmet.2014.08.00 2 Unger, R.H., and P .E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1091/mbc.E12-10-077 4 Van Hul, M., H. Piccard, and H.R.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1160/TH09-10-073 9 Vankoningsloo, S., A.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"119:1266– 1282. http://dx.doi.org/10.1242/jcs.0284 8 Vergnes, L., A.P.",Non-OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1194/jlr   .M500553-JLR20 0 Waldén, T.B., I.R.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1128/MCB.00931-0 6 Wang, C.H., C.C.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1111/j.1749- 6632.2010.05625. x Wang, Q.A., C. Tao, R.K. Gupta, and P.E.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1038/nm.332 4 Wang, Y ., X. Wang, W.B.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"20:103– 118. http://dx.doi.org/10.1016/j.cmet.2014.05.00 5 Wilson-Fritch, L., S. Nicoloro, M. Chouinard, M.A.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1172/   JCI20042175 2 Wu, Z., Y. Xie, R.F.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1172/JCI124 4 Wu, Q., A.M. Ortegon, B. Tsang, H. Doege, K.R.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/   10.1128/MCB.26.9.3455-3467.200 6 Wu, J., P. Boström, L.M.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"150:366– 376. http://dx.doi.org/10.1016/j.cell.2012.05.01 6 Xia, J.Y ., T.S.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi   .org/10.1016/j.biochi.2013.08.01 3 Xu, L., G.A.",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
"http://dx.doi.org/10.1055/s-0030-125503 4 Yamaguchi, S., H. Katahira, S. Ozawa, Y .",OADS,/arxiv_data1/oa_pdf/9e/ea/JCB_201409063.PMC4347644.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
Procedure was performed following manufacturer  protocol (http://www.phos-tag.com).,OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201406020/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1091/mbc.E02-08-054 8 Fredriksson, S., M. Gullberg, J. Jarvius, C. Olsson, K. Pietras, S.M.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/nrg75 8 Gallicano, G.I., P. Kouklis, C. Bauer, M. Yin, V .",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"143:2009– 2022. http://dx.doi.org/10.1083/jcb.143.7.200 9 Gallicano, G.I., C. Bauer, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1172/JCI2775 1 Godsel, L.M., S.N.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.20051003 8 Harmon, R.M., C.L.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1172/JCI6522 0 Hatzfeld, M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/   jid.2011.31 8 Hudson, T.Y ., L. Fontao, L.M.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/   S0091-679X(04)78026- 7 Huen, A.C., J.K. Park, L.M.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.20020609 8 Izawa, I., and M. Inagaki.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1111/j.1349- 7006.2006.00161. x Jamora, C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/ncb0402-e10 1 Jonkman, M.F., A.M.G.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1086/49690 1 Karakesisoglou, I., Y .",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.149.1.19 5 Kiès, P., M. Bootsma, J. Bax, M.J. Schalij, and E.E.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/   10.1016/j.hrthm.2005.10.01 8 Kimura, T.E., A.J.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/sj.jid.570064 3 Kouklis, P.D., E. Hutton, and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.127.4.104 9 Kowalczyk, A.P., and K.J.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/   10.1016/B978-0-12-394311-8.00005- 4 Kowalczyk, A.P., E.A.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
http://dx.doi   .org/10.1083/jcb.139.3.77 3and in part by the Malkin Scholars Program from the Robert H. Lurie Compre - hensive Cancer Center of Northwestern University.,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/j.febslet.2014.02.00 8 Angst, B.D., L.A. Nilles, and K.J.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi   .org/10.3109/15419061.2013.87601 6 Bass-Zubek, A.E., R.P.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.20071213 3 Beausoleil, S.A., M. Jedrychowski, D. Schwartz, J.E.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/   10.1016/j.molcel.2008.12.01 3 Bornslaeger, E.A., C.M.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.134.4.98 5 Bouameur, J.-E., Y. Schneider, N. Begré, R.P.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1242/jcs.12777 9 Brieher, W.M., and A.S. Yap.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 0 Brooke, M.A., D. Nitoiu, and D.P.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1002/   path.302 7 Cha, B., W. Kim, Y .K.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/onc.2010.61 0 Choi, H.-J., and W.I.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"409:800– 812. http://dx.doi.org/10.1016/j.jmb.2011.04.04 6 Choi, H.-J., S. Park-Snyder, L.T.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/378785a 0 Deribe, Y .L., T. Pawson, and I. Dikic.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi   .org/10.1038/nsmb.184 2 Earley, L., L.C.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1021/ac401783 f Etienne-Manneville, S., and A.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/nature0142 3 Fontao, L., B. Favre, S. Riou, D. Geerts, F. Jaunin, J.-H. Saurat, K.J.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1586/epr.10.1 0 Wu, X., Q.-T. Shen, D.S.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/j.molcel.2013.05.00 4 Yang, Z., N.E.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1161/01.RES.0000241482.19382.c 6 Zhang, X., and X. Cheng.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/S0969-2126(03)00071- 6Kröger, C., F. Loschke, N. Schwarz, R. Windoffer, R.E.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1074/jbc   .M111.31666 1 Lai-Cheong, J.E., K. Arita, and J.A.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/sj.jid.570072 7 Leung, C.L., D. Sun, M. Zheng, D.R.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.147.6.127 5 Mahoney, M.G., S. Sadowski, D. Brennan, P. Pikander, P. Saukko, J. Wahl, H.  Aho, K. Heikinheimo, L. Bruckner-Tuderman, A. Fertala, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/jid.2009.35 7 Meng, J.J., E.A.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1074/jbc.272.34.2149 5 Norgett, E.E., S.J.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10   .1093/hmg/9.18.276 1 O’Keefe, E.J., H.P.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 8 Patel, D.M., A.D. Dubash, G. Kreitzer, and K.J.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi   .org/10.1083/jcb.20131211 0 Ruhrberg, C., and F.M.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
http://dx.doi   .org/10.1111/j.1540-8167.2006.00365.,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/nrm317 5 Snider, N.T., and M.B.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/nrm375 3 Söderberg, O., M. Gullberg, M. Jarvius, K. Ridderstråle, K.J.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1038/nmeth94 7 Sonnenberg, A., and R.K.H.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1016/j.yexcr.2007   .03.03 9 Stappenbeck, T.S., J.A.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
"http://dx.doi.org/10.1083/jcb.20110400 9 Sun, T., M. Rodriguez, and L. Kim.",OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
http://dx.doi   .org/10.1111/j.1440-169X.2009.01141.,Non-OADS,/arxiv_data1/oa_pdf/f1/8f/JCB_201406020.PMC4347645.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1371/journal   .pone.000783 0 Bravo-Cordero, J.J., M. Oser, X. Chen, R. Eddy, L. Hodgson, and J. Condeelis.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10   .1016/j.cub.2011.03.03 9 Burman, J.L., L. Bourbonniere, J. Philie, T. Stroh, S.Y .",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/jbc.M80186920 0 Caswell, P.T., and J.C. Norman.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
http://dx.doi.org/10.1111/j.1600-0854.,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1016/j.tcb.2008.03.00 4 Cerami, E., J. Gao, U. Dogrusoz, B.E.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1158/2159-8290.CD-12-009 5 Collins, T.J. 2007.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.2144/00011251 7 Debnath, J., S.K.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1016/S1046-2023(03)00032- X Del Pozo, M.A., W.B.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/ncb75 9 Fanning, A.S., B.J.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"273:29745– 29753. http://dx.doi.org/10.1074/jbc.273.45.2974 5 Fukuda, M., E. Kanno, K. Ishibashi, and T. Itoh.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/mcp   .M700569-MCP20 0 Gao, J., B.A.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"13:813– 820. http://dx.doi.org/10.1038/nrc360 1 Goody, R.S., A. Rak, and K. Alexandrov.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1007/   s00018-005-4486- 8 Guo, W., D. Roth, C. Walch-Solimena, and P. Novick.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1093/emboj/18.4.107 1 Hanna, S., V. Miskolci, D. Cox, and L. Hodgson.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1371/journal.pone.009646 9 Harsay, E., and R. Schekman.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"18:1203– 1219. http://dx.doi.org/10.1091/mbc.E06-11-103 5 Hattula, K., J. Furuhjelm, J. Tikkanen, K. Tanhuanpää, P. Laakkonen, and J.  Peränen.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1016/   S0076-6879(06)06012- 5 Hodgson, L., O. Pertz, and K.M.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1016/S0091-679X(08)85004- 2 Hodgson, L., F. Shen, and K. Hahn.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201407068/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201407068.dv.,OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.12.03 7 Allaire, P.D., M. Seyed Sadr, M. Chaineau, E. Seyed Sadr, S. Konefal, M.  Fotouhi, D. Maret, B. Ritter, R.F.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1091/mbc.E05-10-091 7 Mellman, I., and Y .",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1101/cshperspect.a01694 9 Mo, W., J. Zhang, X. Li, D. Meng, Y. Gao, S. Yang, X. Wan, C. Zhou, F. Guo,  Y. Huang, et al.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10   .1371/journal.pone.005659 2 Mochizuki, N., S. Yamashita, K. Kurokawa, Y. Ohba, T. Nagai, A. Miyawaki,  and M. Matsuda.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1038/3508259 4 Moshfegh, Y., J.J. Bravo-Cordero, V. Miskolci, J. Condeelis, and L. Hodgson.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/ncb297 2 Mourskaia, A.A., E. Amir, Z. Dong, K. Tiedemann, S. Cory, A. Omeroglu, N.  Bertos, V. Ouellet, M. Clemons, G.L.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1186/bcr336 1 Nagai, T., S. Yamada, T. Tominaga, M. Ichikawa, and A. Miyawaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1126/science.110036 7 Nishikimi, A., S. Ishihara, M. Ozawa, K. Etoh, M. Fukuda, T. Kinashi, and K.  Katagiri.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1126/scisignal.200519 9 Nishimura, N., and T. Sasaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1016/S0076-6879(07)38010- 5 Nokes, R.L., I.C.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1083/   jcb.20080217 6 Nookala, R.K., L. Langemeyer, A. Pacitto, B. Ochoa-Montaño, J.C. Donaldson,  B.K.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1002/jcb.24042030 4 Pertz, O., L. Hodgson, R.L.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/nature0466 5 Pfeffer, S.R., A.B.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/jbc.270.29.1705 7 Pignatelli, J., D.A.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.06.01 0 Ritter, B., S. Murphy, H. Dokainish, M. Girard, M.V.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1371/journal.pbio.100167 0 Sakane, A., K. Honda, and T. Sasaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1128/MCB.01067-0 9 Sakane, A., A.A. Abdallah, K. Nakano, K. Honda, W. Ikeda, Y. Nishikawa,  M. Matsumoto, N. Matsushita, T. Kitamura, and T. Sasaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/jbc   .M112.38365 3 Sakane, A., A. Alamir Mahmoud Abdallah, K. Nakano, K. Honda, T. Kitamura,  I. Imoto, N. Matsushita, and T. Sasaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1111/gtc.1207 8Hubbs, A.E., M. Majidi, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/sj.onc.120255 4 Hussain, N.K., S. Jenna, M. Glogauer, C.C.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1038/ncb1001-92 7 Imamura, H., K. Takaishi, K. Nakano, A. Kodama, H. Oishi, H. Shiozaki,  M. Monden, T. Sasaki, and Y. Takai.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10   .1091/mbc.9.9.256 1 Jakobsen, K.R., E. Sørensen, K.K.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"8:9. http://dx.doi.org/10.1186/1750-2187-8- 9 Kanda, I., N. Nishimura, H. Nakatsuji, R. Yamamura, H. Nakanishi, and T.  Sasaki.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/   sj.onc.121081 2 Kang, Y., P.M. Siegel, W. Shu, M. Drobnjak, S.M.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi   .org/10.1016/S1535-6108(03)00132- 6 Kitano, M., M. Nakaya, T. Nakamura, S. Nagata, and M. Matsuda.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/nature0685 7 Klöpper, T.H., N. Kienle, D. Fasshauer, and S. Munro.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"10:71. http://dx.doi.org/10.1186/1741-7007-10-7 1 Knight, J.F., R. Lesurf, H. Zhao, D. Pinnaduwage, R.R.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1093/bioinformatics/bts72 5 Levivier, E., B. Goud, M. Souchet, T.P.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1006/bbrc.2001.565 2 Li, W., K. Li, L. Zhao, and H. Zou.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1016/j.gene.2014.06.04 2 Lichy, J.H., W.S.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1093/nar/24.23.470 0 Lippé, R., M. Miaczynska, V. Rybin, A. Runge, and M. Zerial.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1091/mbc.12.7.221 9 Majidi, M., J.S.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/jbc.275.9.656 0 Marat, A.L., and P.S.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1074/jbc.M109   .05093 0 Marat, A.L., H. Dokainish, and P.S.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1091/mbc.E11-05-047 4 Marzesco, A.M., T. Galli, D. Louvard, and A. Zahraoui.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
http://dx.doi.org/   10.1074/jbc.273.35.2234 0,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"69A:563– 572. http://dx.doi.org/10.1002/cyto.a.2028 3 Spiering, D., J.J. Bravo-Cordero, Y. Moshfegh, V. Miskolci, and L. Hodgson.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1016/   B978-0-12-407761-4.00025- 7 Stenmark, H. 2009.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1038/nrm272 8 Thomann, D., D.R.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
http://dx.doi   .org/10.1046/j.1365-2818.2002.01066.,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi   .org/10.1074/jbc.M80974620 0 Walch-Solimena, C., R.N.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10   .1083/jcb.137.7.149 5 Whitlow, M., B.A.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1093/protein/6.8.98 9 Wu, X., M.J. Bradley, Y. Cai, D. Kümmel, E.M. De La Cruz, F.A.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10.1091/mbc.E07-06-055 1 Yoshimura, S., A. Gerondopoulos, A. Linford, D.J.",Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/10   .1083/jcb.20100805 1 Zhang, D., L.M.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"3:283. http://dx.doi.org/   10.3389/fgene.2012.0028 3 Zhou, K., A. Muroyama, J. Underwood, R. Leylek, S. Ray, S.H.",OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
http://dx.doi.org/   10.1073/pnas.130841911 0,Non-OADS,/arxiv_data1/oa_pdf/8a/03/JCB_201407068.PMC4347646.pdf
"http://dx.doi.org/   10.1038/sj.onc.120664 5 Fulton, A.M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1007/s11912-009-0019- 1 Gao, R., Y. Yu, A. Inoue, N. Widodo, S.C. Kaul, and R. Wadhwa.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1038/7341 7 Groom, J.R., and A.D. Luster.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi   .org/10.1245/s10434-012-2437- 9 Inoue, A., T. Watanabe, K. Tominaga, K. Tsugawa, K. Nishio, K.P.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1242/jcs.0234 5 Inoue, A., S.Y.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1002/med.2129 1 Karantza, V .",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1038/onc.2010.45 6 Kawada, K., M. Sonoshita, H. Sakashita, A. Takabayashi, Y .",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-03-175 7 Kim, S., P. Wong, and P.A.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1038/nature0465 9 Lacotte, S., S. Brun, S. Muller, and H. Dumortier.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/   10.1038/jid.2011.45 3 Li, B., W. Xu, L. Xu, Z. Jiang, Z. Wen, K. Li, and S. Xiong.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1242/dev.06699 3 Lo, B.K., M. Yu, D. Zloty, B. Cowan, J. Shapiro, and K.J.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.2353/   ajpath.2010.08105 9 Mandal, M., R. Vadlamudi, D. Nguyen, R.A. Wang, L. Costa, R. Bagheri- Yarmand, J. Mendelsohn, and R. Kumar.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1074/jbc.M00851420 0 McGowan, K.M., and P.A.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1083/jcb.143.2.46 9 McGowan, K.M., X. Tong, E. Colucci-Guyon, F. Langa, C. Babinet, and P.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1101/gad.97950 2 Mikula, M., and K. Bomsztyk.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi   .org/10.1074/jbc.M110.21333 0 Nielsen, T.O., F.D.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-04-022 0Online supplemental material Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201408026/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201408026.dv.,OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi   .org/10.1038/nrm250 9 Arbeit, J.M., K. Münger, P.M. Howley, and D. Hanahan.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1016/j.canlet.2014.06.01 9 Bernot, K.M., P.A.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10.1046/ j.1523-1747.2002.19518.,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1002/bies.2004 8 Chaudhury, A., P. Chander, and P.H.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/   10.1261/rna.225411 0 Chen, L.C., H.P.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1007/s00403-009-0966- 2 Cho, Y.Y., M.H.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1093/carcin/bgs27 1 Chung, B.M., C.I.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/   10.1074/jbc.M111.30154 9 DePianto, D., M.L.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/   10.1038/ng.66 5 Elinav, E., R. Nowarski, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10   .1038/nrc361 1,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1074/jbc.M111.30204 2 Sankar, S., J.M.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1128/MCB.00241-1 3 Satelli, A., and S. Li.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi   .org/10.1007/s00018-011-0735- 1 Shanmugam, N., M.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"283:36221– 36233. http://dx.doi.org/10.1074/jbc.M80632220 0 Tauler, J., and J.L.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10.1111/j.1432-1033.1995   .tb20370.,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1016/   j.cell.2007.10.00 9 Wan, F., A. Weaver, X. Gao, M. Bern, P.R.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1038/ni.200 7 Wang, Y.F., H.Y.",OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1007/s13277-013-0703- 5 Winkler, A.E., J.J. Brotman, M.E.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1007/s10555-008-9178- z Yates, C.C., R. Bodnar, and A.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"http://dx.doi.org/10.1007/s00018-011-0663- 0 Zhou, R., R. Shanas, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
http://dx.doi.org/10.1002/ijc.2474 4,Non-OADS,/arxiv_data1/oa_pdf/ae/bd/JCB_201408026.PMC4347647.pdf
"Cell Cycle 2014; 13(19):3059-75; http://dx.doi.org/10.4161/15384101.2014.949091 Michelangelo Cordenonsi; Department of Molecular Medicine; University of Padua School of Medicine; Padua, Italy; Email: michelangelo.cordenons i@unipd.it; ;http://dx.doi.org/10.1080/15384101.2015.1006557 Tight junctions (TJ) are specialized macro- molecular structures that connect two adja-cent epithelial cells at the border between theapical and the basolateral membranes.",Non-OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
Nat Rev Mol Cell Biol 2001; 2:285-93; PMID:11283726; http://dx.doi.org/10.1038/35067088 2.,OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
Curr Biol 2014; 24:R815-25; PMID:25202877; http://dx.doi.org/10.1016/j.cub.2014.,OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
"Furuse M, Biochim Biophys Acta 2009; 1788:813-9; PMID:18706387; http://dx.doi.org/10.1016/j.bbamem.2008.07.017 4.",OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
Biochim Biophys Acta 2009; 1788:761-7; PMID:19121284 ; http://dx.doi.org/ 10.1016/j.bbamem.2008.11.024 5.,OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
Cell Cycle 2014; 13(19):3059-75; PMID:25486565; http://dx.doi.org/10.4161/15384101.2014.949091 6.,Non-OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
Physiol Rev 2014; 94:1287-312; PMID:25287865; http://dx.doi.org/10.1152/physrev.,Non-OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
"00005.2014© Michelangelo Cordenonsi This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/dc/kccy-14-472.PMC4347688.pdf
"18Covalent attachment of Lys48-linked polyubi- quitin to target proteins promotes their proteasomal degradation, whereas Lys63-linked polyubiquitination modulates the activity or trafﬁcking of the substrate protein.19-22 We recently reported a mechanism whereby TGF bpro- motes the invasiveness of cancer cells.23-25TGFbinduces the © Reshma Sundar, Shyam Kumar Gudey, Carl-Henrik Heldin, and Marene Landstr €om *Correspondence to: Marene Landstr €om; Email: Marene.Landstrom@medbio.umu.se Submitted: 06/15/2014; Revised: 11/17/2014; Accepted: 11/17/2014 http://dx.doi.org/10.4161/15384101.2014.990302 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Cancer Metast Rev 2014; 33:511-25; PMID:24414228; http://dx.doi.org/ 10.1007/s10555-014-9494-4 2.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nat Rev Mol Cell Biol 2012; 13:616-30; PMID:22992590; http://dx.doi.org/10.1038/nrm3434 3.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Curr Opin Cell Biol 2009; 21:166-76; PMID:19237272; http://dx.doi.org/ 10.1016/j.ceb.2009.01.021 4.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Mol Cell 2008; 29:157-68; PMID:18243111; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Cell 2008; 134:215- 30; PMID:18662538; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
"Cell Tissue Res 2012; 347:11-20;PMID:21701805; http://dx.doi.org/10.1007/s00441- 011-1201-y 8 .S o u c h e l n y t s k y iS ,T a m a k iK ,E n g s t r o mU ,W e r n - stedt C, ten Dijke P, Heldin CH.",Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
J Biol Chem 1997; 272:28107-15; PMID:9346966; http://dx.doi.org/10.1074/jbc.272.44.28107 9.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Cell 1996; 87:1215-24; PMID:8980228; http://dx.doi.org/ 10.1016/S0092-8674(00)81817-6 10.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Fut Oncol2009; 5:1-3; PMID:19243289; http://dx.doi.org/ 10.2217/14796694.5.1.1 12.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
EMBO J 2000; 19:1745-54; PMID:10775259; http://dx.doi.org/ 10.1093/emboj/19.8.1745 13.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
J Cell Sci 2005; 118:3573-84; PMID:16105881;http://dx.doi.org/10.1242/jcs.02554 14.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nat Cell Biol 2008; 10:1199-207; PMID:18758450; http://dx.doi.org/10.1038/ncb178016.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Mol Cell 2008; 31:918- 24; PMID:18922473; http://dx.doi.org/10.1016/j.molcel.2008.09.002 17.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Curr Opin Genet Dev 2011; 21:21-8; PMID:21071203;http://dx.doi.org/10.1016/j.gde.2010.10.004 18.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Annu Rev Biochem 1998; 67:425-79; PMID:9759494; http://dx.doi.org/10.1146/annurev.biochem.67.1.425 19.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nat Struct Mol Biol 2008; 15:20-2; PMID:18176551; http://dx.doi.org/10.1038/nsmb0108-20 20.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nature 2009; 458:438-44; PMID:19325623; http://dx.doi.org/10.1038/nature07960 21.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Curr Opin Chem Biol 2004;8:610-6; PMID:15556404; http://dx.doi.org/10.1016/ j.cbpa.2004.09.009 23.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nat Commun 2011; 2:330; PMID:21629263; http://dx.doi.org/10.1038/ncomms1332 24.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Sci Signaling 2014; 7:ra2; PMID:24399296; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Cell Cycle 2014; 13; PMID:24945502; http://dx.doi.org/10.4161/cc.29339 26.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Fut Oncol 2014; 10:1853-61; PMID:24597658; http://dx.doi.org/ 10.2217/fon.14.45 27.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
J Cell Physiol 1997; 173:447-59; PMID:9369958;http://dx.doi.org/10.1002/(SICI)1097-4652(199712) 173:3%3c447::AID-JCP17%3e3.0.CO;2-8 28.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Int J Biochem Cell Biol 2010; 42:585-9; PMID:20060931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Mol Cell 2013; 51:559-72; PMID:23973329; http://dx.doi.org/ 10.1016/j.molcel.2013.07.014 31.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Virchows Archiv: Int J Pathol 2004; 444:313-23; PMID:14968363; http://dx.doi.org/10.1007/s00428- 003-0971-3 32.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Minire- view: cyclin D1: normal and abnormal functions.Endocrinology 2004; 145:5439-47; PMID:15331580; http://dx.doi.org/10.1210/en.2004-0959 33.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Genes Dev 1998; 12:3008-19; PMID:9765203; http://dx.doi.org/10.1101/gad.12.19.3008 35.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Cell Cycle2012; 11:4642-9; PMID:23187803; http://dx.doi.org/ 10.4161/cc.22937 37.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
MEK drives cyclin D1 hyperelevation during geroconversion.Cell Death Differ 2013; 20:1241-9; PMID:23852369; http://dx.doi.org/10.1038/cdd.2013.86 38.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Oncogene 2008; 27:366-77; PMID:17637753; http://dx.doi.org/ 10.1038/sj.onc.1210643 39.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
J Biol Chem 1995; 270:23589- 97; PMID:7559524; http://dx.doi.org/10.1074/jbc.270.40.23589 40.,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
EMBO J 1999; 18:188-97; PMID:9878062 [http://dx.doi.org/10.1093/emboj/18.1.188 41.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Nature 1988; 334:535-7;PMID:3136397; http://dx.doi.org/10.1038/334535a0 42.,Non-OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
Exp Cell Res 1993; 207:1-7; PMID:7686495; http://dx.doi.org/10.1006/excr.1993.1156 www.tandfonline.com 565 Cell Cycle,OADS,/arxiv_data1/oa_pdf/00/5f/kccy-14-554.PMC4347693.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/04/88/cardiovascmed-04-01-25472.PMC4347722.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6b/49/cardiovascmed-03-04-25715.PMC4347723.pdf
"This is an open-access article dis - tributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/30/eb/cardiovascmed-03-04-21772.PMC4347724.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.Dear Editor, Salivary gland tumors consist of about 3% of all head and  neck tumors.",Non-OADS,/arxiv_data1/oa_pdf/93/06/iranjradiol-12-01-6921.PMC4347725.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/59/6c/iranjradiol-11-04-11393.PMC4347726.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/c3/2d/cardiovascmed-03-04-25237.PMC4347727.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/82/28/iranjradiol-11-04-14441.PMC4347728.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bd/82/cardiovascmed-04-01-25547.PMC4347729.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/bd/4a/iranjradiol-11-04-11069.PMC4347730.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/28/02/iranjradiol-12-01-11405.PMC4347731.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e0/a2/iranjradiol-11-04-14887.PMC4347752.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.Dear Editor, Neonatal cholestasis (NC) is defined as prolonged el - evation of serum levels of conjugated bilirubin beyond  two weeks of life.",Non-OADS,/arxiv_data1/oa_pdf/a8/a1/iranjradiol-11-04-6382.PMC4347753.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ab/54/cardiovascmed-03-04-18423.PMC4347754.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/36/e7/iranjradiol-11-04-18114.PMC4347755.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6e/d6/iranjradiol-11-04-10513.PMC4347756.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b0/9b/cardiovascmed-03-04-25173.PMC4347757.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/52/ce/iranjradiol-12-01-12708.PMC4347758.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ce/c4/iranjradiol-12-01-13547.PMC4347759.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/a4/23/iranjradiol-11-04-5316.PMC4347760.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.Dear Editor, We read with interest the paper by Sari et al.",Non-OADS,/arxiv_data1/oa_pdf/a6/aa/iranjradiol-11-04-18738.PMC4347761.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f3/4d/iranjradiol-12-01-12026.PMC4347762.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f3/99/iranjradiol-11-04-10848.PMC4347791.pdf
"This is an open-access article dis - tributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which  permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/89/d1/cardiovascmed-03-04-20159.PMC4347792.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/7f/d1/cardiovascmed-03-04-22941.PMC4347793.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/89/c1/cardiovascmed-04-01-25592.PMC4347794.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fd/7e/iranjradiol-12-01-12556.PMC4347795.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.Cardiac synchrony is defined as coordinated distribu - tion of electrical activation through a prescribed path  across the heart, leading to a harmonic contraction of  contractile elements.",Non-OADS,/arxiv_data1/oa_pdf/5b/0d/cardiovascmed-04-01-25851.PMC4347796.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate-rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/90/e6/iranjradiol-11-04-10107.PMC4347797.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/65/00/iranjradiol-12-01-7054.PMC4347798.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/94/b3/iranjradiol-12-01-14258.PMC4347799.pdf
"This is an open-access article distributed under the terms  of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redis - tribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/79/a0/cardiovascmed-03-04-20720.PMC4347800.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/d1/ae/iranjradiol-11-04-13575.PMC4347801.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/cf/main.PMC4347832.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.07.009 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/61/cf/main.PMC4347832.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/cf/main.PMC4347832.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4347905.pdf
"Meanwhile,the 3rd blood gas analysis revealed pH 7.01, Lac 15 mmol/L, BE−20.3 mmol/L, and Glu 21.3 mmol/L, another 150 ml of 5% NaCO 3 http://dx.doi.org/10.1016/j.ijscr.2014.09.026 2210-2612/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4347905.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/41/main.PMC4347905.pdf
e-mail: someya@cc.kyoto-su.ac.jp ©2015 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/22/77/jvms-77-037.PMC4347921.pdf
Clustal W. http://clustalw.ddbj.nig.ac.jp/.,Non-OADS,/arxiv_data1/oa_pdf/22/77/jvms-77-037.PMC4347921.pdf
http://www.nih.go.jp/niid/ja/idwr.html.,Non-OADS,/arxiv_data1/oa_pdf/22/77/jvms-77-037.PMC4347921.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/69/main.PMC4347955.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.11.078 2210-2612/© 2014 Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/b3/69/main.PMC4347955.pdf
This is an open access article under the CC BY-NC-ND license(http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/69/main.PMC4347955.pdf
"Reynolds, Necrotising pancreatitis presenting as a painful mass in the groin and sepsis, BMJ Case Rep. (2013),http://dx.doi.org/10.1136/bcr-2013-008726 .",Non-OADS,/arxiv_data1/oa_pdf/b3/69/main.PMC4347955.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/1e/main.PMC4347956.pdf
An intraoperative ultrasound scan (IOUS) conﬁrmedthe preoperative ﬁndings and excluded other metastases in liver http://dx.doi.org/10.1016/j.ijscr.2014.09.025 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/19/1e/main.PMC4347956.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/1e/main.PMC4347956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/a0/main.PMC4347957.pdf
"Ten days following gastric leak repair, an upper gastrointestinal series conﬁrmed a persistent leak at the proximal staple line as well http://dx.doi.org/10.1016/j.ijscr.2014.11.077 2210-2612/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/73/a0/main.PMC4347957.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/a0/main.PMC4347957.pdf
"S1550-7289 (June (13)) (2013)180–189, http://dx.doi.org/10.1016/j.soard.2013.05.007 .",OADS,/arxiv_data1/oa_pdf/73/a0/main.PMC4347957.pdf
"206 (May(5)) (2009) 935–938, http://dx.doi.org/10.1016/j.jamcollsurg.2008.02.016 .",OADS,/arxiv_data1/oa_pdf/73/a0/main.PMC4347957.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/6e/main.PMC4347958.pdf
"3 Due to the scarcity of primary GAS peritonitis, only case reports and small case series have been published during the last http://dx.doi.org/10.1016/j.ijscr.2014.10.060 2210-2612/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/53/6e/main.PMC4347958.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/53/6e/main.PMC4347958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/27/main.PMC4347959.pdf
The GP http://dx.doi.org/10.1016/j.ijscr.2014.12.024 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/main.PMC4347959.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dc/27/main.PMC4347959.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/00/main.PMC4347960.pdf
"Early RV thrombosis Late RV thrombosis Time course Within 2 weeks post-transplant6Greater than 2 weekspost-transplant Incidence 0.4–6% 60.5–4% Causes Kink in the renal vein Kink in the renal vein Anastomotic stenosis Anastomotic stenosisDiminished ﬂow 1Diminished ﬂowCompression of renalvein 5,7 Prognosis Poor Very poor http://dx.doi.org/10.1016/j.ijscr.2014.09.0272210-2612/Published by Elsevier Ltd. on behalf of Surgical Associates Ltd.",Non-OADS,/arxiv_data1/oa_pdf/fe/00/main.PMC4347960.pdf
This is an open access article under the CC BY-NC-SA license(http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fe/00/main.PMC4347960.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/5a/main.PMC4347961.pdf
A segmental bowel resection was http://dx.doi.org/10.1016/j.ijscr.2014.09.001 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/5a/main.PMC4347961.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/5a/main.PMC4347961.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/24/main.PMC4347962.pdf
The lung windows showed http://dx.doi.org/10.1016/j.ijscr.2014.09.028 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/24/main.PMC4347962.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/24/main.PMC4347962.pdf
Tuberculosis ; 2002 http://www.who.int/en/ [online 13.03.14].,Non-OADS,/arxiv_data1/oa_pdf/70/24/main.PMC4347962.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/94/main.PMC4347963.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.09.023 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/94/main.PMC4347963.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f4/94/main.PMC4347963.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/58/main.PMC4347964.pdf
http://dx.doi.org/10.1016/j.ijscr.2014.09.011 2210-2612/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/60/58/main.PMC4347964.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/58/main.PMC4347964.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/5d/main.PMC4347965.pdf
"Abdominal ultrasound (US) and computerized tomography (CT) scan showed an encapsulated hypodense solid mass with cys-tic components and areas of enhancement, extending from the http://dx.doi.org/10.1016/j.ijscr.2014.08.015 2210-2612/© 2014 The Authors.",OADS,/arxiv_data1/oa_pdf/88/5d/main.PMC4347965.pdf
This is an open access article under the CC BY-NC-ND lic ense (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/88/5d/main.PMC4347965.pdf
"Small submu- cosal tumors of the stomach: differentiation of gastric schwannoma fromgastrointestinal stromal tumor with CT. Korean J Radiol 2012; 13(4):425–33, http://dx.doi.org/10.3348/kjr.2012.13.4.425 .",Non-OADS,/arxiv_data1/oa_pdf/88/5d/main.PMC4347965.pdf
http://www.cancer.gov/cancertopics/pdq/treatment/gist/HealthProfessionls(last modiﬁed 07.09.2011).,Non-OADS,/arxiv_data1/oa_pdf/88/5d/main.PMC4347965.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1111/j.0016-7363.2005.00671.x .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://urbanomnibus.net/2010/03/norcs-in-nyc/ 〉 Bashir SA.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1093/epirev/ mxf007 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"〈http://www.nytimes.com/2010/03/20/nyregion/20homeless.html 〉 [30 July 2012] Brash, J. Bloomberg's New York: Class and Governance in the Luxury City.",Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved  from: 〈http://nycfuture.org/research/publications/the-new-face-of-new-yorks-seniors 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1016/j.jhe.2013.03.003 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1016/j.healthplace.2004.11.002 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1093/aje/155.1.80 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from:  〈http://advocate.nyc.gov/sites/advocate.nyc.gov/files/DeBlasio-NYCHA-Repairs-Fact-Sheet.pdf 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1016/S0094-1190(03)00080-9 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.2105/AJPH.91.11.1783 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1111/0735-2166.00096 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1016/0013-9351(75)90069-9 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"Retrieved from: 〈http://furmancenter.org/files/ publications/HVS_Rent_Stabilization_fact_sheet_FINAL_4.pdf 〉 [5 June 2014] Gotbaum, B.",Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from:  〈http://www.gothamgazette.com/article/housing/20091005/10/3045 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
2013; 121197(2) http://dx.doi.org/10.1289/ehp.1104625 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1016/ j.socscimed.2006.07.030 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1007/s00704-008-0017-5 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1289/ehp.1205919 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1055/s-2007-1009479 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
New York Archives Trust; 2008. p. 8-11.Retrieved from:  〈http://www.archives.nysed.gov/apt/magazine/archivesmag_summer08.pdf 〉 [6 June 2014]Rosenthal et al.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1289/ehp.5957 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1146/annurev.publhealth.18.1.341 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"2013. http://dx.doi.org/10.1038/ NCLIMATE1902 Link BG, Phelan JC.",Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://comptroller.nyc.gov/wp-content/uploads/ documents/NYC_SeniorHousing.pdf 〉.,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"Retrieved from: 〈http://www.massresources.org/utility- discounts.html 〉 McGeehin MA, Mirabelli M. The potential impacts of climate variability and change on temperature- related morbidity and mortality in the United States.",Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"Retrieved  from: 〈http://www.rfcom.ca/glossary/index.shtml 〉 Metzger KB, Ito K, Matte TD.",Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1289/ehp.0900906 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved  from: 〈http://www.nationalgridus.com/masselectric/home/rates/4_lowincome.asp 〉.,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
2014 Retrieved from: 〈http://www.nytimes.com/2014/04/30/nyregion/older-new-yorkers-face- acute-pain-in-finding-homes.html 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://www.nrdc.org/ej/mold-and-moisture-in- public-housing.asp 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Dec. 2006 2006 Retrieved from: 〈http://www.nyc.gov/ html/dcp/pdf/census/projections_report.pdf 〉.,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://www.nyc.gov/html/dfta/html/services/retirement.shtml 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved  from: 〈http://www.nyc.gov/html/doh/downloads/pdf/survey/survey-2006heatdeaths.pdf 〉 New York City Department of Health and Mental Hygiene (NYCDOHMH).,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://www.nyc.gov/html/doh/html/cd/cdheat-illness-and- waves.shtml 〉 New York City Rent Guidelines Board (NYCRGB).,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
Retrieved from: 〈http://www.nycrgb.org/ html/guide/basics.html 〉.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1097/JOM.,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1093/ jurban/jti043 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1038/nature04188 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1177/002214650404500303 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.4278/0890-1171-21.4s.326 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.2105/AJPH.,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1136/jech.2008.078147 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1016/ S0277-9536(98)00237-8 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/ 10.1175/1520-0450(1979)018<0861:TAOSPI4>2.0.CO;2 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1093/ije/dyn359 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.2105/AJPH.84.5.825 .,Non-OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
"Retrieved from: 〈http://otda.ny.gov/programs/heap/ 〉 Uejio CK, Wilhelmi OV, Golden JS, Mills DM, Gulino SP, Samenow JP.",OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
http://dx.doi.org/10.1016/ j.healthplace.2010.12.005 .,OADS,/arxiv_data1/oa_pdf/75/48/nihms-662101.PMC4348023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/34/opth-9-373.PMC4348047.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 373–377Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  373Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7831 9Causes of isolated recurrent ipsilateral sixth  nerve palsies in older adults: a case series  and review of the literature Jane W Chan1,2 Jeff albretson3 1Department of Neurology,   2Department of Ophthalmology,   College of Medicine, University of  arizona, Phoenix, aZ, Usa; 3University  of Nevada, Las Vegas, NV,  UsaPurpose:  The etiology of recurrent isolated sixth nerve palsies in older adults has not been  well described in the literature.",Non-OADS,/arxiv_data1/oa_pdf/a7/34/opth-9-373.PMC4348047.pdf
"Sixth nerve palsies were the most common in this study cohort and they were  acute and non-recurrent.2 The current study focuses on a subpopulation of isolated  relapsing-remitting sixth nerve palsies in which we present evidence that mass lesions Correspondence: Jane W Chan Barrow Neurological institute, 240 W  Thomas road, suite 401, Phoenix,   aZ 85013, Usa Tel +1 602 406 4239 Fax +1 602 406 4606 email worjun@aol.co m Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2015 Volume: 9 Running head verso: Chan and Albretson Running head recto: Causes of isolated recurrent ipsilateral sixth nerve palsies DOI: http://dx.doi.org/10.2147/OPTH.S78319",Non-OADS,/arxiv_data1/oa_pdf/a7/34/opth-9-373.PMC4348047.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a7/34/opth-9-373.PMC4348047.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/34/opth-9-373.PMC4348047.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/27/opth-9-367.PMC4348048.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 367–371Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  367Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7874 3Evaluation of the efficacy and safety of a new  device for eye drops instillation in patients  with glaucoma Daniela M Junqueira1 Flavio s lopes1,2 Fabiola C de souza1 syril Dorairaj3 Tiago s Prata1,2 1glaucoma Unit, hospital Medicina  dos Olhos, Osasco, Brazil;  2Department of Ophthalmology,   Federal University of são Paulo,   são Paulo, Brazil; 3Department  of Ophthalmology, Mayo Clinic,   Jacksonville, Fl, UsaObjective:  This study evaluated the efficacy and safety of a new device (Eyedrop®) designed  for eye drop instillation in patients with and without glaucoma.",Non-OADS,/arxiv_data1/oa_pdf/cf/27/opth-9-367.PMC4348048.pdf
"Although Correspondence: Tiago santos Prata glaucoma service, Department of  Ophthalmology, Federal University  of são Paulo, rua eloi Cândido lopes,  294 Osasco, são Paulo, Brazil Tel +55 11 3683 0404 Fax +55 11 2659 1738 email t.prata0807@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Junqueira et al Running head recto: Safety of Eyedrop® for eye drops instillation in glaucoma patients DOI: http://dx.doi.org/10.2147/OPTH.S78743",Non-OADS,/arxiv_data1/oa_pdf/cf/27/opth-9-367.PMC4348048.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/cf/27/opth-9-367.PMC4348048.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/27/opth-9-367.PMC4348048.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1225–1231Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1225Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7372 3Fluorescence detection of tramadol in healthy  chinese volunteers by high-performance liquid  chromatography and bioequivalence assessment Xiao Zhou Ji liu Department of anesthesia, shanghai  Pulmonary hospital, T ongji University  school of Medicine, shanghai, People’s  republic of chinaAbstract:  This study developed a revised high-performance liquid chromatography fluorescence  method to determine plasma tramadol concentration, and thereby to examine the bioequivalence  of two tramadol formulations among healthy male Chinese volunteers.",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
"It is  mostly eliminated via biotransformation in the liver in two main pathways: O-demethyla - tion to O-desmethyltramadol (M1) (the pharmacologically active metabolite) by   isoenzyme cytochrome P450 2D6 (CYP2D6), and N-demethylation to N-desmethyltra - madol (M2) by cytochromes (CYP2B6 and CYP3A4).2 Among these metabolites, only  O-desmethyltramadol (M1 metabolite) is pharmacologically active.3 Approximately  10%–30% of the parent drug is excreted unmetabolized in the urine.3,4correspondence: Ji liu  Department of anesthesia, shanghai  Pulmonary hospital, Tongji University  school of Medicine, 507 Zheng Min  road, Yangpu, shanghai 200433, People’s  republic of china Tel +86 21 6511 5006 Fax +86 21 6511 5006 email liuji0515@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Zhou and Liu Running head recto: Fluorescence detection of tramadol by HPLC DOI: http://dx.doi.org/10.2147/DDDT.S73723",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
"Available from: http://www.sefig.com/doc/Congreso%20 Granada/013_DOC.pd f. Accessed November 1, 2010.",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/1d/dddt-9-1225.PMC4348049.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 429–438International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  429OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7612 4The effect of comorbidities on COPD assessment:  a pilot study Ulla Møller Weinreich1–3 lars Pilegaard Thomsen2 Barbara Bielaska4 Vania helbo Jensen5,6 Morten Vuust4 stephen edward rees2 1Department of respiratory Diseases,   aalborg University hospital, aalborg,   Denmark; 2respiratory and Critical  Care group ( rCare), Centre for  Model-Based Medical Decision  support systems, Department  of health science and T echnology,   aalborg University, aalborg,   Denmark; 3The Clinical Institute,   aalborg University hospital, aalborg,   Denmark; 4Department of radiology,   Vendsyssel hospital, hjørring,   Denmark; 5Department of radiology,   horsens regional hospital, horsens,   Denmark; 6Department of radiology,   aalborg University hospital, aalborg,   DenmarkIntroduction:  Patients with chronic obstructive pulmonary disease (COPD) frequently suffer  from comorbidities.",Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
"Recent studies  have found patients to suffer from 4–6 comorbidities on average.2,3 Comorbidities  have been shown to be associated with mortality3,4 and quality of life,5 and to  influence the outcome of the Modified Medical Research Council Dyspnea Scale  (mMRC) score.6 Correspondence: Ulla Møller Weinreich Department of respiratory Diseases,  aalborg University hospital,  Mølleparkvej 4, DK-9000 aalborg,  Denmark Tel +45 97 66 47 35 Fax +45 97 66 35 77 email ulw@rn.d kJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Weinreich et al Running head recto: Effect of comorbidities on COPD assessment DOI: http://dx.doi.org/10.2147/COPD.S76124",Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
"Available from: http://www.goldcopd.org/uploads/users/files/ GOLDReport07_0108.pd f. Accessed December 12, 2014.",OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
Available from: http://www.goldcopd.,Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/58/copd-10-429.PMC4348050.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/81/30/dddt-9-1233.PMC4348051.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1233–1245Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1233Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7977 2Pharmacokinetic-pharmacodynamic analysis to  evaluate the effect of moxifloxacin on QT interval  prolongation in healthy Korean male subjects Taegon hong1,2 seunghoon han1,2 Jongtae lee1,2 sangil Jeon1,2 gab-Jin Park1,2 Wan-su Park1,2 Kyoung soo lim3 Jae-Y ong chung4 Kyung-sang Yu3 Dong-seok Yim1,2 1Department of Pharmacology,   college of Medicine, the catholic  University of Korea, seoul, republic  of Korea; 2PiPeT (Pharmacometrics  institute for Practical education and  Training), the catholic University  of Korea, seoul, republic of Korea;   3Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine and  hospital, seoul, republic of Korea;   4Department of clinical Pharmacology  and Therapeutics, seoul national  University college of Medicine  and Bundang hospital, seongnam,   republic of KoreaAbstract:  A single 400 mg dose of moxifloxacin has been the standard positive control for  thorough QT (TQT) studies.",Non-OADS,/arxiv_data1/oa_pdf/81/30/dddt-9-1233.PMC4348051.pdf
"However, these methods do not consider interindividual differences.6 Nonlinear correspondence: Dong-seok Yim Department of Pharmacology, college  of Medicine, the catholic University  of Korea, 222 Banpodaero, seochogu,  seoul, republic of Korea Tel +82 2 2258 7327  Fax +82 2 2258 7876 email yimds@catholic.ac.k rJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hong et al Running head recto: PK-PD model for QT prolongation by moxifloxacin DOI: http://dx.doi.org/10.2147/DDDT.S79772",Non-OADS,/arxiv_data1/oa_pdf/81/30/dddt-9-1233.PMC4348051.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/81/30/dddt-9-1233.PMC4348051.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/81/30/dddt-9-1233.PMC4348051.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 379–392Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  379ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7581 2Refractive outcomes of an advanced aspherically  optimized profile for myopia corrections by  LASIK: a retrospective comparison with the  standard aspherically optimized profile Bertram Meyer1 Georg Sluyterman van  Langeweyde2 Matthias Wottke2 1Augencentrum Köln, Cologne,   Germany; 2Carl Zeiss Meditec AG,   Jena, GermanyPurpose:  A retrospective comparison of refractive outcomes of a new, aspherically optimized  profile with an enhanced energy correction feature (Triple-A) and the conventionally used  aspherically optimized profile (ASA, or aberration smart ablation) for correction of low-to- high myopia.",Non-OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
"The introduction of femtosec - ond laser flap creation has significantly reduced flap-related complications.2 More Correspondence: Bertram Meyer Augencentrum Köln, Josefstraße 14,   51143 Cologne, Germany Email b ertram.meyer@t-online.d e Journal name: Clinical Ophthalmology Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 9 Running head verso: Meyer et al Running head recto: Outcomes of an aspherically optimized profile for myopia corrections DOI: http://dx.doi.org/10.2147/OPTH.S75812",Non-OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/4c/82/opth-9-379.PMC4348052.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/a6/ott-8-471.PMC4348053.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 471–485OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  471Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7343 8assessment of selected cytokines, proteins,  and growth factors in the peritoneal fluid  of patients with ovarian cancer and benign  gynecological conditions anita Monika  Chudecka-Głaz1 aneta alicja  Cymbaluk-Płoska1 Janusz Leszek Menkiszak1 ewa Pius-sadowska2 Bogusław  Bronisław  Machaliński2 Agnieszka  Sompolska-   Rzechuła3 Izabella Anna  Rzepka-Górska1 1Department of gynecological  surgery and gynecological Oncology  of adults and adolescents, Pomeranian  Medical University,  Szczecin,  Poland;  2Department  of general Pathology,   Pomeranian Medical University,   Szczecin,  Poland; 3Department of  Mathematics applications in economy,   West Pomeranian University of  Technology,  Szczecin,  PolandObjectives:  The ovarian tumor microenvironment, ie, the peritoneal fluid, is an intriguing  research subject.",Non-OADS,/arxiv_data1/oa_pdf/aa/a6/ott-8-471.PMC4348053.pdf
"The accumulation of peritoneal fluid in this type of cancer is related primarily to correspondence:  anita Monika  Chudecka-Głaz Department of gynecological surgery  and gynecological Oncology of  adults and adolescents, Pomeranian  Medical University, Al Powstańców  Wielkopolskich 72, Pl-70-111  Szczecin, Poland Tel +48 91 466 1332 Fax +48 91 466 1334 email anitagl@poczta.onet.p l Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Chudecka-Głaz et al Running head recto: Cytokines and growth factors in peritoneal fluid DOI: http://dx.doi.org/10.2147/OTT.S73438",Non-OADS,/arxiv_data1/oa_pdf/aa/a6/ott-8-471.PMC4348053.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/a6/ott-8-471.PMC4348053.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/a6/ott-8-471.PMC4348053.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/25/cpaa-7-037.PMC4348054.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 37–56Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S7962 6Carbon monoxide: a critical quantitative analysis  and review of the extent and limitations of its  second messenger function David G Levitt1 Michael D Levitt2 1Department of integrative Biology  and Physiology, University of  Minnesota, Minneapolis, MN, USA;   2Research Service, veterans Affairs  Medical Center, Minneapolis, MN, USA Correspondence: David G Levitt,  Department of integrative Biology and  Physiology, University of Minnesota,  6-125 Jackson Hall, 321 Church St S e,  Minneapolis, MN 55455, USA   Tel +1 612 625 7649   Fax +1 612 625 5149   email levit001@umn.ed uAbstract:  Endogenously produced carbon monoxide (CO) is commonly believed to be a ubiq - uitous second messenger involved in a wide range of physiological and pathological responses.",Non-OADS,/arxiv_data1/oa_pdf/ae/25/cpaa-7-037.PMC4348054.pdf
"Bethesda, MD:  Federation of American Societies for Experimental Etiology; 1971:16.  http://www2.epa.gov/sites/production/files/2014-03/documents/ leidyref.pd f.  69.",Non-OADS,/arxiv_data1/oa_pdf/ae/25/cpaa-7-037.PMC4348054.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/ae/25/cpaa-7-037.PMC4348054.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/25/cpaa-7-037.PMC4348054.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1247–1255Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1247Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7759 7Noncoding RNAs as potential biomarkers  to predict the outcome in pancreatic cancer Kaizhou Jin1–3,* Guopei Luo1–3,* Zhiwen Xiao1–3 Zuqiang Liu1–3 Chen Liu1–3 Shunrong Ji1–3 Jin Xu1–3 Liang Liu1–3 Jiang Long1–3 Quanxing Ni1–3 Xianjun Yu1–3 1Department of Pancreatic  and Hepatobiliary Surgery, Fudan  University Shanghai Cancer Center,   2Department of Oncology, Shanghai  Medical College, Fudan University,   3Pancreatic Cancer institute, Fudan  University, Shanghai, People’s Republic  of China *These authors contributed equally  to this workAbstract:  Pancreatic ductal adenocarcinoma (PDAC), a common digestive system cancer,  is highly malignant and has a poor disease outcome.",Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
"Additionally, in the  metastatic setting, only clinical prognostic factors, such as imaging examinations and  serum tumor markers, are available to guide treatment decision making.4–6 Carbohydrate antigen 19-9 (CA19-9) has been extensively used to screen for PDAC  in blood and predict the clinical cancer outcome.7,8 However, several benign diseases  and multiple types of digestive adenocarcinoma, particularly advanced gastrointestinal  cancers, may cause elevated serum CA19-9 levels, which suggests that the specificity  of CA19-9 requires improvement for PDAC outcome predication.9 In the majority  of patients with benign biliary obstruction, CA-19-9 levels are significantly elevated  (1,000 U/mL).10 Therefore, it is difficult to distinguish whether high preoperative Correspondence: Xianjun Yu Department of Pancreatic and  Hepatobiliary Surgery, Fudan  University, Shanghai Cancer Center,  270 Dong An Road, Shanghai 200032,  People’s Republic of China Tel +86 21 6417 5590 Fax +86 21 6403 1446 email yuxianjun@fudan.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Jin et al Running head recto: Noncoding RNAs in pancreatic cancer DOI: http://dx.doi.org/10.2147/DDDT.S77597",Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
Available from: http://www.mirbase.org /.,Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/f1/dddt-9-1247.PMC4348055.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4a/83/copd-10-423.PMC4348056.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 423–428International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  423OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7893 7Functional capacity, physical activity, and quality  of life in hypoxemic patients with chronic  obstructive pulmonary disease Melda saglam1 naciye Vardar-Yagli1 sema savci2 Deniz Inal-Ince1 ebru Calik-Kutukcu1 hülya arikan1 lutfi Coplu3 1Department of Physiotherapy  and rehabilitation, Faculty  of health sciences, hacettepe  University, ankara, T urkey; 2school  of Physiotherapy and rehabilitation,   Dokuz eylul University, Izmir, T urkey;   3Department of Chest Medicine,   Faculty of Medicine, hacettepe  University, ankara, T urkeyBackground:  The risk of hypoxemia increases with the progression of chronic obstructive  pulmonary disease (COPD) and the deterioration of pulmonary function.",Non-OADS,/arxiv_data1/oa_pdf/4a/83/copd-10-423.PMC4348056.pdf
"Complications  and extrapulmonary comorbidities including cardiovascular disorders, pulmonary  hypertension, polycythemia, neurocognitive dysfunction, impairment of life quality,  lower exercise tolerance, and skeletal muscle weakness are common, and the risk of  death is increased with the presence of hypoxemia in COPD.7–9Correspondence: Melda saglam Department of Physiotherapy  and rehabilitation, Faculty of health  sciences, hacettepe University, 06100,  samanpazari, ankara, Turkey Tel +90 312 305 1577 ext 123 Fax +90 312 305 2012 email msaglam@hacettepe.edu.t r Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Saglam et al Running head recto: Hypoxemia in COPD DOI: http://dx.doi.org/10.2147/COPD.S78937",Non-OADS,/arxiv_data1/oa_pdf/4a/83/copd-10-423.PMC4348056.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4a/83/copd-10-423.PMC4348056.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/83/copd-10-423.PMC4348056.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 487–493OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  487Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7890 3Validation of the Memorial sloan Kettering  cancer center nomogram for predicting  non-sentinel lymph node metastasis in sentinel  lymph node-positive breast-cancer patients Xiang Bi1,* Y ongsheng Wang2 Minmin li1,* Peng chen2 Zhengbo Zhou2 Yanbing liu2 T ong Zhao2 Zhaopeng Zhang2 chunjian Wang2 Xiao sun2 Pengfei Qiu2 1school of Medicine and life sciences,   University of Jinan- shandong academy  of Medical sciences, shandong cancer  hospital, 2Breast cancer center,   shandong cancer hospital, Jinan,   People’s republic of china *These authors contributed equally  to this studyBackground:  The main purpose of the study reported here was to validate the clinical value of  the Memorial Sloan Kettering Cancer Center (MSKCC) nomogram that predicts non-sentinel  lymph node (SLN) metastasis in SLN-positive patients with breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
"Numerous studies have shown  that SLN was the unique lymph node with tumor metastasis in 40%–70% patients with  breast cancer.2,3 Therefore identifying SLN-positive breast cancer patients with non- SLN metastasis at low risk has become a research hotspot in recent years, as ALND  can then be avoided in these patients.correspondence: Yongsheng Wang Breast cancer center, shandong cancer  hospital, no 440 Jiyan road, huaiyin  District, Jinan, shandong 250117, People’s  republic of china Tel/Fax +86 531 6762 6215 email wangysh2008@aliyun.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Bi et al Running head recto: MSKCC nomogram for predicting non-SLN metastasis in SLN + breast cancer DOI: http://dx.doi.org/10.2147/OTT.S78903",Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
We logged in to the MSKCC website at http://nomograms.mskcc.org/Breast/BreastAdditionalNonSLNMetastasesPage.,Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/bf/ott-8-487.PMC4348057.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 133–143ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  133ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7574 3Health services financing and delivery: analysis of  policy options for Dubai, United Arab Emirates samer hamidi School of Health and Environmental  Studies, Hamdan Bin Mohammed  Smart University, Dubai, United Arab  Emirates Correspondence: samer hamidi   School of Health and Environmental  Studies, Hamdan Bin Mohammed Smart  University, PO Box 71400, Dubai,  United Arab Emirates   Tel +971 4 424 1089   Email s.hamidi@hbmsu.ac.a eIntroduction:  A national health account (NHA) provides a systematic approach to mapping  the flow of health sector funds within a specified health system over a defined time period.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Abbreviations:  AED, Arab Emirates dirham; m, million; DHA, Dubai Health Authority; MOH, Ministry of Health.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Bold values show main  schemes and functions.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthcare_statistics .,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Bold values show main  schemes and functions.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available  from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthcare_statistic s. Accessed November 28, 2014.5 “Inpatient care” refers to curative and rehabilitative care  in inpatient and day care settings.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthcare_statistic s. Accessed November 28, 2014.5 Abbreviation:  OECD, Organization for Economic Cooperation and Development.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.isahd.ae/content/docs/HASD%20English%202012.pd f. Accessed 15 July, 2014.3 Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthcare_statistic s. Accessed November 28, 2014.5",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Avail - able from: http://www.dsc.gov.ae/EN/Themes/Pages/Publications.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: https://www.dha.gov.ae/ EN/SectorsDirectorates/Sectors/HealthPolicy/Pages/HealthDataand- InformationAnalysis.asp x. Accessed July 15, 2014.",OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from:  http://www.isahd.ae/content/docs/HASD%20English%202012.pd f.  Accessed 15 July, 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://ec.europa.eu/eurostat/statistics- explained/index.php/Healthcare_statistic s. Accessed November 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.oecd.org/els/health- systems/49105858.pd f. Accessed November 28, 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.oecd.org/dataoecd/41/4/1841456.pd f.  Accessed November 28, 2014.",OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.oecd.org/els/ health-systems/Health-at-a-Glance-2013.pd f. Accessed November 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.moh.gov.ae/en/OpenData/Pages/Open - Data.aspx?Category=All%20Open%20Dat a. Accessed November 28,  2014.",OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available from: http://stats.oecd.org/glossary/detail.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: https://www.prevent.org/data/files/initiatives/economic- argumentfordiseaseprevention.pd f. Accessed July 16, 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Avail - able from: http://www.oecd.org/berlin/46201464.pd f. Accessed July  16,  2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
"Available from: http://www.oecd.org/els/ health-systems/33661480.pd f. Accessed July 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available from: http://www.haiweb.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available from: http://www.alpencapital.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available  from: http://www.who.int/features/factfiles/ universal_health_coverage/ en/.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
Available from: http://www.who.int/health_financing/ documents/cov-wprosearo-strategy2010/en /.,Non-OADS,/arxiv_data1/oa_pdf/17/09/ceor-7-133.PMC4348058.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/rru-7-019.PMC4348059.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 19–33Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  19Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S5897 4Management of erectile dysfunction   post-radical prostatectomy Alan Saleh Hamid Abboudi MB Ghazal-Aswad erik K Mayer Justin A vale Division of Surgery and Cancer,   imperial College Healthcare NHS  Trust, St Mary’s Hospital, London, UK Correspondence: Hamid Abboudi   Division of Surgery and Cancer, imperial  College Healthcare NHS Trust,   St Mary’s Hospital, Praed Street,   London w2  1NY, UK   Tel +44 20 3312 6666  Fax +44 20 8296 8789  email hamid.abboudi@doctors.org.u kAbstract:  Radical prostatectomy is a commonly performed procedure for the treatment of  localized prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/rru-7-019.PMC4348059.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/fa/66/rru-7-019.PMC4348059.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/66/rru-7-019.PMC4348059.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/f1/tcrm-11-289.PMC4348120.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 289–299Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  289Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S3759 2Advances in diagnosis and treatment of  trigeminal neuralgia Nicola Montano1 Giulio Conforti1 Rina Di Bonaventura1 Mario Meglio2 eduardo Fernandez1 Fabio Papacci1 1institute of Neurosurgery, Catholic  University, Rome, 2institute of   Neurosurgery, Azienda Ospedaliera  Universitaria integrata, verona, italyAbstract:  Various drugs and surgical procedures have been utilized for the treatment of  trigeminal neuralgia (TN).",Non-OADS,/arxiv_data1/oa_pdf/32/f1/tcrm-11-289.PMC4348120.pdf
"It has been recently shown that TN is  the most frequent type of facial pain2 and that, among facial pain syndromes, the  overall incidence of TN has remained constant3 ranging from 12.6/100,000/year2 to  27/100,000/year.3 TN is uncommon in population younger than 40  years (overall inci - dence of 0.2/100,000/year) and increases in incidence with advancing age, occurring  in 25.9/100,000/year in individuals older than 80 years.4 TN appears to be slightly  more common among women and has both classical and symptomatic ( ~15% of  cases) subtypes with the former most often associated with a neurovascular conflict  of the trigeminal nerve in the prepontine cistern.5 The right side is more frequently Correspondence: Nicola Montano institute of Neurosurgery, Catholic  University, Largo Agostino Gemelli,  8, 00168 Rome, italy Tel +39 6 3015 4120 Fax +39 6 305 1343 email nicolamontanomd@yahoo.i t Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Montano et al Running head recto: Diagnosis and treatment of trigeminal neuralgia DOI: http://dx.doi.org/10.2147/TCRM.S37592",Non-OADS,/arxiv_data1/oa_pdf/32/f1/tcrm-11-289.PMC4348120.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/32/f1/tcrm-11-289.PMC4348120.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/f1/tcrm-11-289.PMC4348120.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/22/sar-6-041.PMC4348121.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 41–50Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  41ORiginAl ReSeARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S7877 3Prevalence of and factors associated with   regular khat chewing among university   students in ethiopia Ayalew Astatkie1 Meaza Demissie2 Yemane Berhane2 Alemayehu Worku2,3 1School of Public and environmental  health, college of Medicine and  health Sciences, hawassa University,   hawassa, ethiopia; 2Addis continental  institute of Public health, Addis  Ababa, ethiopia; 3School of Public  health, college of health Sciences,   Addis Ababa University, Addis Ababa,   ethiopia correspondence:  Ayalew Astatkie   PO Box 1643, hawassa, ethiopia   Tel +251 91 173 9694   email ayalewastatkie@gmail.co mPurpose:  Khat ( Catha edulis ) is commonly chewed for its psychostimulant and euphorigenic  effects in Africa and the Arabian Peninsula.",Non-OADS,/arxiv_data1/oa_pdf/de/22/sar-6-041.PMC4348121.pdf
"Available from: https://en.wikipedia.org/wiki/Hawassa_Universit y.  Accessed November 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/de/22/sar-6-041.PMC4348121.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/de/22/sar-6-041.PMC4348121.pdf
Visit http://www.dovepress.com/testimonials.php   to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/22/sar-6-041.PMC4348121.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/74/prbm-8-071.PMC4348122.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 71–79Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  71Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S7497 2Current perspectives on attachment and bonding  in the dog–human dyad elyssa Payne1 Pauleen C Bennett2 Paul D McGreevy1 1Faculty of veterinary Science,   University of Sydney, Sydney, NSw ,   Australia;  2School of Psychological  Science, La Trobe University, Bendigo,    viC, Australia Correspondence: elyssa Payne   RMC Gunn Building, University   of Sydney, Sydney, NSw, Australia   Tel +61 4 0222 5335  email epay1031@uni.sydney.edu.a uAbstract:  This article reviews recent research concerning dog–human relationships and how  attributes that arise from them can be measured.",Non-OADS,/arxiv_data1/oa_pdf/1e/74/prbm-8-071.PMC4348122.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/1e/74/prbm-8-071.PMC4348122.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1e/74/prbm-8-071.PMC4348122.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/ee/ndt-11-461.PMC4348123.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 461–470Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  461OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7883 0electroencephalography reveals lower  regional blood perfusion and atrophy  of the temporoparietal network associated  with memory deficits and hippocampal volume  reduction in mild cognitive impairment due  to alzheimer’s disease Davide Vito Moretti National institute for the research  and cure of alzheimer’s disease,    s. John of god, Fatebenefratelli,   Brescia, italyBackground:  An increased electroencephalographic (EEG) upper/lower alpha power ratio has  been associated with less regional blood perfusion, atrophy of the temporoparietal region of the  brain, and reduction of hippocampal volume in subjects affected by mild cognitive impairment  due to Alzheimer’s disease as compared with subjects who do not develop the disease.",Non-OADS,/arxiv_data1/oa_pdf/aa/ee/ndt-11-461.PMC4348123.pdf
"In line with recently published correspondence: Davide Vito Moretti National institute for the research  and care of alzheimer’s Disease,  san giovanni di Dio Fatebenefratelli,  Brescia, italy Tel +39 030 3501 597 Fax +39 030 3533 513 email davide.moretti@afar.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Moretti Running head recto: Atrophy and decreased perfusion in temporoparietal network in AD DOI: http://dx.doi.org/10.2147/NDT.S78830",Non-OADS,/arxiv_data1/oa_pdf/aa/ee/ndt-11-461.PMC4348123.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/aa/ee/ndt-11-461.PMC4348123.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/ee/ndt-11-461.PMC4348123.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/c7/ndt-11-477.PMC4348124.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 477–484Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  477OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7517 6hyperprolactinemia during antipsychotics treatment  increases the level of coagulation markers Masamichi ishioka Norio Yasui-Furukori Norio sugawara hanako Furukori shuhei Kudo Kazuhiko Nakamura  Department of Neuropsychiatry,   graduate school of Medicine,   hirosaki University, hirosaki, JapanObjective:  The strong association between psychiatric patients who receive antipsychotics and  the incidence of venous thromboembolism (VTE) is known.",Non-OADS,/arxiv_data1/oa_pdf/88/c7/ndt-11-477.PMC4348124.pdf
"Almost all studies have suggested a positive relationship between antipsychotic use  and VTE, and these studies have estimated a wide range of risk from 1.1 to 29.3,9–18  with only one study indicating negative findings.17  Because the prolactin response to antipsychotics is related to dopamine D2-receptor  blockade,19–21 hyperprolactinemia is a frequent consequence of certain antipsychotic correspondence: Norio Yasui-Furukori Department of Neuropsychiatry,  graduate school of Medicine, hirosaki  University, hirosaki 036-8562, Japan Tel +81 172 39 5066 Fax +81 172 39 5067 email yasufuru@cc.hirosaki-u.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Ishioka et al Running head recto: Hyperprolactinemia during antipsychotics treatment increases DOI: http://dx.doi.org/10.2147/NDT.S75176",Non-OADS,/arxiv_data1/oa_pdf/88/c7/ndt-11-477.PMC4348124.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/88/c7/ndt-11-477.PMC4348124.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/c7/ndt-11-477.PMC4348124.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/35/12/tcrm-11-301.PMC4348125.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 301–307Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  301Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/TCRM.S5902 3Optimal management of Ménière’s disease Carol A Foster Department of Otolaryngology,   University of Colorado School  of Medicine, Aurora, Colorado, USAAbstract:  Confusion in the nomenclature of Ménière’s disease and lack of a standard defini - tion of the disorder until 1995 has hampered accurate assessment of treatment efficacy since  the presently defined disorder was first described in 1938.",Non-OADS,/arxiv_data1/oa_pdf/35/12/tcrm-11-301.PMC4348125.pdf
"There have been two major opposing factions  since the Hallpike and Cairns paper was published.1 One broad group believes that  endolymphatic hydrops and Ménière’s disease are synonymous and that treatments  directed at hydrops should be sufficient to control symptoms.3 Within this “hydrops  group”, it is currently believed that the onset of hydrops is probably multifactorial, Correspondence: Carol A Foster Department of Otolaryngology,  University of Colorado School of   Medicine, 12631 east 17th Avenue,  Mailstop B205, Aurora, CO 80045, USA Tel +1 303 724 1967 Fax +1 303 724 1961 email carol.foster@ucdenver.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Foster Running head recto: Management of Ménière’s disease DOI: http://dx.doi.org/10.2147/TCRM.S59023",Non-OADS,/arxiv_data1/oa_pdf/35/12/tcrm-11-301.PMC4348125.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/35/12/tcrm-11-301.PMC4348125.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/35/12/tcrm-11-301.PMC4348125.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 517–531Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  517OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7597 5T oward an online cognitive and emotional battery  to predict treatment remission in depression evian gordon1 a John rush2 Donna M Palmer3,4 Taylor a Braund3 William rekshan1 1Brain resource, san Francisco, ca,   Usa; 2Duke-NUs, singapore; 3Brain  resource, sydney, N sW, australia;   4Brain Dynamics center, sydney  Medical school – Westmead and  Westmead Millennium institute, The  University of sydney, sydney, N sW,   australiaPurpose:  To evaluate the performance of a cognitive and emotional test battery in a repre - sentative sample of depressed outpatients to inform likelihood of remission over 8 weeks of  treatment with each of three common antidepressant medications.",Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
"Remission is  the goal of treatment,4 yet less than 50% of patients achieve remission with their initial  treatment.5–7 Presently, selecting the best treatment for depressed patients rests on a trial correspondence: evian gordon Brain resource, 115 sansome st, suite  600-B, san Francisco, ca 94104, Usa Tel +1 415 399 7990 Fax +1 415 852 5198 email eviang@brainresource.u sJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Gordon et al Running head recto: Test battery to predict remission in depressed outpatients DOI: http://dx.doi.org/10.2147/NDT.S75975",Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
URL: http://www.clinicaltrials.gov/ct2/ show/NCT00693849?term =ispot-D&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
Available  from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
Available from: http://CRAN.R-project.org/ package=caret.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
Available from: http://CRAN.R-project.org/package =Epi.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/07/ndt-11-517.PMC4348126.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/bb/tcrm-11-319.PMC4348127.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 319–327Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  319ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7766 9Role of physiotherapy and patient education  in lymphedema control following breast cancer  surgery shiang-Ru lu1 Rong-Bin hong2 Willy Chou3,4 Pei-Chi hsiao3,4 1Department of neurology, Kaohsiung  Medical University hospital,   Kaohsiung, Taiwan; 2Departments of  Physical Medicine and Rehabilitation,   Chi-Mei Medical Center  liouying Campus, Tainan, Taiwan;   3Department of Physical Medicine  and Rehabilitation, Chi-Mei Medical  Center, Tainan, Taiwan; 4Department  of Recreation and health Care  Management, Chia nan University of  Pharmacy and science, Tainan, TaiwanIntroduction:  This retrospective cohort study evaluated whether education in combination  with physiotherapy can reduce the risk of breast cancer-related lymphedema (BCRL).",Non-OADS,/arxiv_data1/oa_pdf/1b/bb/tcrm-11-319.PMC4348127.pdf
"Gross and fine motor skills are affected, the daily functions  are restricted, and psychosocial relationship is impeded.3 Previous studies have identified several risk factors associated with the occurrence  of BCRL, which include the following: arm infection, inflammation, or injury;2,4–6 over - weight or weight gain;2,4–7 aging;4 surgery on the dominant arm;4,6 level of hand use;5  a higher number of removed axillary lymph nodes;7 being married;7 having received a  mastectomy,8 ALND,8 radiation therapy,6,8 or chemotherapy;7 pathological status of the Correspondence: Pei-Chi hsiao Department of Physical Medicine and  Rehabilitation, Chi-Mei Medical Center,  no 901, Zhonghua Road, Yongkang  District, Tainan 71004, Taiwan Tel +886 6 281 2811 ext 53745 email peichi1227@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Lu et al Running head recto: Education and physiotherapy for breast cancer-related lymphedema DOI: http://dx.doi.org/10.2147/TCRM.S77669",Non-OADS,/arxiv_data1/oa_pdf/1b/bb/tcrm-11-319.PMC4348127.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/1b/bb/tcrm-11-319.PMC4348127.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/bb/tcrm-11-319.PMC4348127.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/eb/vhrm-11-149.PMC4348128.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 149–155Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  149ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7370 3effectiveness and tolerability of second-line  treatment with vildagliptin versus other oral  drugs for type  2 diabetes in a real-world setting   in the Middle east: results from the eDge study charles saab1 Feryal a al-saber2 Jihad Haddad3 Mahir Khalil Jallo4 Habib steitieh5 giovanni Bader6 Mohamed ibrahim7 1Department of endocrinology and  Metabolism, sacre coeur University  Hospital, Baabda, lebanon;  2endocrine  Department, Bahrain Defence Force  Hospital, Rifaa, Bahrain;  3Division  of endocrinology Department of  internal Medicine, Prince Hamaza  Hospital, amman, Jordan;  4Department  of internal Medicine, gulf Medical  University, ajman, United arab  emirates;  5new Mowasat Hospital,   safat, Kuwait;  6novartis Pharma ag,   Basel, switzerland;  7novartis Pharma  services ag, Dubai, United arab  emirates correspondence: Mohamed ibrahim   novartis Pharma services ag, Mena  cluster, PO Box 23510 Dubai, United  arab emirates   Tel +971 4435 7038  Fax +971 4435 7701  email mohamed-1.ibrahim@novartis.co mBackground:  Type  2 diabetes mellitus (T2DM) is a chronic progressive disease that requires  treatment intensification with antihyperglycemic agents due to progressive deterioration of  β-cell function.",Non-OADS,/arxiv_data1/oa_pdf/1b/eb/vhrm-11-149.PMC4348128.pdf
Available from: http://www.idf.org/diabetesatlas/data-visualisations .,OADS,/arxiv_data1/oa_pdf/1b/eb/vhrm-11-149.PMC4348128.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/1b/eb/vhrm-11-149.PMC4348128.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/eb/vhrm-11-149.PMC4348128.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 339–348Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  339PeRsPeCTivesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7820 2integrating risk minimization planning throughout  the clinical development and commercialization  lifecycle: an opinion on how drug development  could be improved elaine H Morrato1 Meredith Y smith2 1Colorado school of Public Health,   University of Colorado, Anschutz  Medical Campus, Aurora, CO, 2eMD  serono, inc, Rockland, MA, UsAAbstract:  Pharmaceutical risk minimization programs are now an established requirement in  the regulatory landscape.",Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Outside of REMS, the increased  use of boxed warnings and patient-directed medication guides has also contributed to  growing risk minimization efforts in the US.4 This transformation has been essentially codified in the recent publications by the  European Medicines Agency (EMA) of the European Union Good Pharmacovigilance Correspondence: elaine H Morrato Colorado school of Public Health,  University of Colorado, Anschutz Medical  Campus, 13001 east 17th Place, Mail stop  B119, Aurora, CO 80045, UsA Tel +1 303 724 1535 Fax +1 303 724 1939 email elaine.morrato@ucdenver.ed u Journal name: Therapeutics and Clinical Risk Management Article Designation: Perspectives Y ear: 2015 Volume: 11 Running head verso: Morrato and Smith Running head recto: Risk minimization planning DOI: http://dx.doi.org/10.2147/TCRM.S78202",Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Available from:  http://www.fda.gov/Drugs/DrugSafety/ postmarketdrugsafetyinform ationforpatientsandp roviders /ucm111350.ht m. Accessed February 4,  2015.",Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Available from:  http://www.fda.gov/AboutFDA/ WhatWeDo/History/Overviews/ucm304485.ht m. Accessed February  4, 2015.",OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
Available from: http://www.fda.gov/cber/guidelines.,Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Available from:  http://www.pcori.org/content/what-we-mean-engagemen t. Accessed  October 30, 2014.",Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
"Available from: http://www.pcori.org/ assets/2014/08/PCORI-Engagement-Rubric-with-Table.pd f. Accessed  October 12, 2014.",OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
Available from:  http://blogs.law.harvard.,Non-OADS,/arxiv_data1/oa_pdf/58/52/tcrm-11-339.PMC4348129.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 119–130Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  119ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7664 9The association between lower back pain   and health status, work productivity,   and health care resource use in Japan alesia B sadosky1 Marco DiBonaventura2 Joseph c cappelleri3 nozomi ebata4 Koichi Fujii4 1Pfizer inc, new Y ork, nY, Usa;   2Kantar health, new Y ork, nY, Usa;   3Pfizer inc, groton, cT, Usa; 4Pfizer  Japan inc, T okyo, Japan correspondence: Marco DiBonaventura   Kantar health, 11 Madison avenue,  12th Floor, new York, nY 10010, Usa   Tel +1 212 706 3988   Fax +1 212 647 7659   email marco.dibonaventura@ kantarhealth.co mIntroduction:  This study investigated the effect of pain severity on health status, work   productivity, health care resource use, and costs among respondents with lower back pain  (LBP), in Japan.",Non-OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
"Available from: http://www.census.gov/population/ international /data/idb/informationGateway.ph p. Accessed December  19, 2014.",OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
"Available from: http://www.mhlw.go.jp/topics/medias/year/13/ dl/iryouhi_data.pd f. Accessed September 3, 2014.",OADS,/arxiv_data1/oa_pdf/80/16/jpr-8-119.PMC4348130.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c2/c2/vhrm-11-165.PMC4348131.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 165–172Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  165ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7090 7Extended-release niacin/laropiprant significantly  improves lipid levels in type  2 diabetes mellitus  irrespective of baseline glycemic control Harold E Bays1 eliot a Brinton2 Joseph Triscari3 erluo chen3 Darbie Maccubbin3 alexandra a Maclean3 Kendra l gibson3 Rae ann Ruck3 Amy O Johnson-Levonas3 edward a O’n eill3 Yale B Mitchel3 1louisville Metabolic &  atherosclerosis Research center  (l-MaRc), louisville, KY, Usa;  2Utah  Foundation for Biomedical Research,   Salt Lake City, UT, USA;  3Merck & co,   inc., Whitehouse station, nJ, Usa correspondence: Yale B Mitchel   Merck Research laboratories,  cardiovascular Disease, RY34-a228,  Merck & co, inc., PO Box  2000,   Rahway, NJ  07065, Usa   Tel +1 732 594 4147  Fax +1 732 594 4610  email yale.mitchel@merck.co mBackground:  The degree of glycemic control in patients with type  2 diabetes mellitus (T2DM)  may alter lipid levels and may alter the efficacy of lipid-modifying agents.",Non-OADS,/arxiv_data1/oa_pdf/c2/c2/vhrm-11-165.PMC4348131.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c2/c2/vhrm-11-165.PMC4348131.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/c2/vhrm-11-165.PMC4348131.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/a4/opth-9-393.PMC4348132.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 393–397Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  393Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7721 0Ocular manifestations of rheumatoid arthritis  and their correlation with anti-cyclic citrullinated  peptide antibodies ammapati Paul Pandian  Vignesh renuka srinivasan Department of Ophthalmology,   Jawaharlal institute of Postgraduate  Medical education and research,   Pondicherry, indiaPurpose:  To study the ocular manifestations of rheumatoid arthritis and to correlate  the role of  anti-cyclic citrullinated peptide antibody (anti-CCP antibody) with the ocular  manifestations.",Non-OADS,/arxiv_data1/oa_pdf/66/a4/opth-9-393.PMC4348132.pdf
"Anti-CCP antibody is emerging as the preferred diagnostic marker for RA especially Correspondence: ammapati Paul Pandian  Vignesh Department of Ophthalmology,  Jawaharlal institute of Postgraduate  Medical education and research,  12 Kamaraj street, Tagore nagar,  Pondicherry 605008, india Tel +91 98 9491 0033 email apvicky2010@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Vignesh and Srinivasan Running head recto: Ocular manifestations of RA and their correlation with anti-CCP antibodies DOI: http://dx.doi.org/10.2147/OPTH.S77210",Non-OADS,/arxiv_data1/oa_pdf/66/a4/opth-9-393.PMC4348132.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/66/a4/opth-9-393.PMC4348132.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/a4/opth-9-393.PMC4348132.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/tcrm-11-309.PMC4348133.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 309–318Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  309Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S6428 8Clinical use of azelnidipine in the treatment of  hypertension in Chinese patients Bi-Lian Chen1,* Yin-Zhuang Zhang1,* Jian-Quan Luo2,3 wei Zhang2,3 1Department of Geriatrics, Xiangya  Hospital, Central South University,   Changsha, Hunan, People’s Republic  of China; 2Department of Clinical  Pharmacology, Xiangya Hospital,   Central South University, Changsha,   Hunan, People’s Republic of China;   3institute of Clinical Pharmacology,   Central South University, Changsha,   Hunan, People’s Republic of China *These authors contributed equally to  this workBackground:  Hypertension is the most common chronic disease and the calcium channel  antagonist is the most popularly used antihypertensive drug in Chinese patients.",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/tcrm-11-309.PMC4348133.pdf
"The 2010 Chinese guideline for the management of hypertension is an update of the  previous ones in 1999 and 2005, and it has covered blood pressure (BP) measurement,  diagnosis, epidemiologic studies, assessment of risk factors, BP monitoring, manage - ment of lifestyle, and drug therapy.1 The prevalence of hypertension had been investigated in the People’s Republic  of China in the years 1958, 1979, 1991, and 2002, especially the last one based Correspondence: wei Zhang Department of Clinical Pharmacology,  Xiangya Hospital, Central South  University, Changsha, Hunan 410008,  People’s Republic of China Tel +86 731 8480 5380 email yjsd2003@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Chen et al Running head recto: Azelnidipine for hypertension in Chinese patients  DOI: http://dx.doi.org/10.2147/TCRM.S64288",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/tcrm-11-309.PMC4348133.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/aa/ac/tcrm-11-309.PMC4348133.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/ac/tcrm-11-309.PMC4348133.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/84/ndt-11-485.PMC4348134.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 485–491Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  485OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7791 0a case-control proton magnetic resonance  spectroscopy study confirms cerebellar dysfunction  in benign adult familial myoclonic epilepsy lili long1 Yanmin song1 linlin Zhang2 chongyu hu3 Jian gong2 lin Xu1 hongyu long1 luo Zhou1 Yunci Zhang2 Y ong Zhang2 Bo Xiao1 1Department of Neurology, Xiangya  Hospital, Central South University,   Changsha, Hunan Province,   People’s Republic of China; 2The  People’s Hospital of Fuyang, Anhui  Province, People’s Republic of  China; 3Department of Neurology,   Hunan Provincial People’s Hospital,   People’s  Republic of ChinaBackground:  Benign adult familial myoclonic epilepsy (BAFME) is a rare form of epilepsy  syndrome.",Non-OADS,/arxiv_data1/oa_pdf/16/84/ndt-11-485.PMC4348134.pdf
"To date, nearly  100 BAFME families (mainly in Japan and Europe) have been reported under sev - eral different disease names, including BAFME, familial adult myoclonic epilepsy  (FAME), familial cortical tremor and epilepsy (FCTE), familial cortical myoclonic  tremor with epilepsy (FCMTE), and autosomal dominant cortical myoclonus and  epilepsy (ADCME).2–6 Genetic studies have revealed that BAFME presents significant  genetic heterogeneity, and four disease loci (8q24, 2p11.1-q12.2, 5p15.31-p15.1, and  3q26.32-3q28) have been identified.7–10 To date, however, no causative genes have  been discovered.correspondence: Bo Xiao Department of Neurology, Xiangya  Hospital, Central South University,  Changsha, Hunan 410008, People’s  Republic of China Tel +86 731 8432 7216 email xiaobo1962_xy@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Long et al Running head recto: ¹H-MRS study in BAFME DOI: http://dx.doi.org/10.2147/NDT.S77910",Non-OADS,/arxiv_data1/oa_pdf/16/84/ndt-11-485.PMC4348134.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric­disease­and­treatment­journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/16/84/ndt-11-485.PMC4348134.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/84/ndt-11-485.PMC4348134.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/1a/ndt-11-507.PMC4348135.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 507–516Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  507OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7383 6Minocycline upregulates cyclic aMP response  element binding protein and brain-derived  neurotrophic factor in the hippocampus  of cerebral ischemia rats and improves  behavioral deficits correspondence:  Zhiyou cai Department of Neurology, renmin  hospital, hubei University of Medicine,  shiyan renmin hospital, No 39  chaoyang road, shiyan, hubei Province,  442000, People’s republic of china Tel +81 719 863 7114 Fax +81 719 866 6352  email c0909@hotmail.co m Yu Zhao1 Ming Xiao2 Wenbo he3 Zhiyou cai3  1Department of Neurology,   the Fourth affiliated hospital of  harbin Medical University, harbin,   heilongjiang Province, People’s  republic of china; 2Department  of anatomy, Nanjing Medical  University, Nanjing, Jiangsu, People’s  republic of china; 3Department of  Neurology, renmin hospital, hubei  University of Medicine, shiyan renmin  hospital, shiyan, hubei Province,   People’s  republic of chinaBackground and purpose:  The cAMP response element binding protein (CREB) plays an  important role in the mechanism of cognitive impairment and is also pivotal in the switch from  short-term to long-term memory.",Non-OADS,/arxiv_data1/oa_pdf/f5/1a/ndt-11-507.PMC4348135.pdf
"Keywords:  vascular cognitive impairment, cAMP response element binding protein, cerebral  ischamia, neuroprotection Introduction Increasing findings have evidenced that cerebral ischemia plays a critical role in the  pathogenesis of vascular cognitive impairment, and the reduction of cerebral blood flow Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Zhao et al Running head recto: Minocycline upregulates CREB and BDNF in the hippocampus DOI: http://dx.doi.org/10.2147/NDT.S73836",Non-OADS,/arxiv_data1/oa_pdf/f5/1a/ndt-11-507.PMC4348135.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f5/1a/ndt-11-507.PMC4348135.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/1a/ndt-11-507.PMC4348135.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/ef/ott-8-509.PMC4348136.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 509–518OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  509Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7695 8nimotuzumab abrogates acquired radioresistance  of KY se-150r esophageal cancer cells by inhibiting  egFr signaling and cellular Dna repair hai liu1 Weifang Yang2 huaping gao3 Tingting Jiang1 Bengxin gu1 Qinghua Dong4 Wenhong Xu5 shixiu Wu6 Xiaonan sun1 1Department of radiation Oncology, sir  run run shaw hospital, sir run run shaw  institute of clinical Medicine of Zhejiang  University, hangzhou, People’s republic of  china; 2Department of radiation Oncology,   laboratory of cellular and Molecular  radiation Oncology, Taizhou hospital,   Wenzhou Medical college, Taizhou,   People’s republic of china; 3Department  of Pharmacy, sir run run shaw hospital,   school of Medicine, Zhejiang University,   hangzhou, People’s republic of china;   4Biomedical research center, sir run run  shaw hospital, school of Medicine, Zhejiang  University, hangzhou, People’s republic  of china; 5Department of radiation  Oncology, The second affiliated hospital,   school of Medicine, Zhejiang University,   People’s republic of china; 6Department  of radiation Oncology, hangzhou cancer  hospital, Wushan District, hangzhou First  People’s hospital, hangzhou, People’s  republic of chinaBackground:  Acquired radioresistance of cancer is common after repeated irradiation and  often leads to treatment failure.",Non-OADS,/arxiv_data1/oa_pdf/88/ef/ott-8-509.PMC4348136.pdf
"correspondence: Xiaonan sun Department of radiation Oncology,  sir run run shaw hospital, sir run  run shaw institute of clinical Medicine  of Zhejiang University, 3 Qinchun road,  hangzhou, Zhejiang 310016, People’s  republic of china Tel +86 571 8609 6916 Fax +86 571 8604 4817 email sunxiaonan@hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: Nimotuzumab abrogates acquired radioresistance DOI: http://dx.doi.org/10.2147/OTT.S76958",Non-OADS,/arxiv_data1/oa_pdf/88/ef/ott-8-509.PMC4348136.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/88/ef/ott-8-509.PMC4348136.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/ef/ott-8-509.PMC4348136.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 347–354Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  347OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7738 0Dietary education must fit into everyday life:  a qualitative study of people with a Pakistani  background and type 2 diabetes nana F hempler1 sara nicic1 Bettina ewers2 ingrid Willaing1 1health Promotion research, steno  Diabetes center, gentofte, Denmark;   2nutrition and Food services  Department, steno Diabetes center,   gentofte, DenmarkBackground:  The high prevalence of diabetes among South Asian populations in European  countries partially derives from unhealthy changes in dietary patterns.",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
"Keywords:  dietary diabetes education, healthy food choices, Pakistani background, type 2  diabetes, patient perspectives, preferences Introduction In European countries, members of South Asian populations who originate from India,  Pakistan, Bangladesh, and Sri Lanka are at a higher risk of developing overweight,  obesity, and type 2 diabetes than are members of the host population.1–7 In Denmark,  the largest group of South Asians comprises immigrants from Pakistan.8 The age- adjusted prevalence of type 2 diabetes in immigrants from Pakistan is approximately  14%, whereas prevalence rates are 7.9% among Pakistanis residing in Pakistan and  2.0% among Danish-born people residing in Denmark.7,9,10 It is suggested that the increased prevalence of type 2 diabetes in South Asian  populations derives from an interplay between life style and genetic factors.5 The  greater prevalence of diabetes among South Asians settled in Europe than that among  South Asians of similar cultural and genetic background in their country of origin sug - gests that health behavior, which includes dietary habits, plays a significant role in the  development of diabetes.11 Studies also show that rates of diabetes complications, such correspondence: nana F hempler health Promotion research, steno  Diabetes center, niels steensens Vej 8,  2820 gentofte, Denmark Tel +45 4073 2591 Fax +45 4443 8235 email nfhr@steno.d k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hempler et al Running head recto: Perspectives on dietary education and healthy food choices DOI: http://dx.doi.org/10.2147/PPA.S77380",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
Available from: http://www.cfk.,Non-OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
"Available  from: http://mighealth.net/uk/images/5/56/System.do c. Accessed  November 11, 2014.",OADS,/arxiv_data1/oa_pdf/a3/fa/ppa-9-347.PMC4348137.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/56/vhrm-11-157.PMC4348138.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 157–164Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  157ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S5320 3Strokes in young adults: epidemiology   and prevention Dževdet Smajlović Department of Neurology, University  Clinical Centre Tuzla, School of  Medicine, University of Tuzla, Bosnia  and Herzegovina Correspondence: Dževdet Smajlović   Department of Neurology, University  Clinical Centre Tuzla, Trnovac bb,   75 000 Tuzla, Bosnia and Herzegovina   email dzsmajlovic@hotmail.co mAbstract:  Strokes in young adults are reported as being uncommon, comprising  10%–15% of  all stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/41/56/vhrm-11-157.PMC4348138.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/41/56/vhrm-11-157.PMC4348138.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/56/vhrm-11-157.PMC4348138.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ott-8-519.PMC4348139.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 519–528OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  519Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3079 3An update on PARP inhibitors for the   treatment of cancer Sarah Benafif Marcia Hall Mount vernon Cancer Centre,   Northwood, Middlesex, UK Correspondence: Marcia Hall   Mount vernon Cancer Centre,  Rickmansworth Road, Northwood,  Middlesex, UK   T el +44 1923 844134 or     +44 7979 537544   email marcia.hall@nhs.ne tAbstract:  The development of poly (adenosine diphosphate [ADP]) ribose polymerase (PARP)  inhibitors (PARPi) has progressed greatly over the last few years and has shown encouraging  results in the BRCA1 /2 mutation–related cancers.",Non-OADS,/arxiv_data1/oa_pdf/fc/46/ott-8-519.PMC4348139.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/fc/46/ott-8-519.PMC4348139.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fc/46/ott-8-519.PMC4348139.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/4a/oajsm-6-049.PMC4348140.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 49–54Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  49OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7026 3Does whole-body cryotherapy improve vertical  jump recovery following a high-intensity   exercise bout?,Non-OADS,/arxiv_data1/oa_pdf/0c/4a/oajsm-6-049.PMC4348140.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/0c/4a/oajsm-6-049.PMC4348140.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/4a/oajsm-6-049.PMC4348140.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1f/ce/opth-9-399.PMC4348141.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 399–402Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  399Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S7784 4Varicella zoster virus-associated anterior uveitis  in a seronegative adult without a history of  chickenpox Izumi Mine sho Ishikawa Masaru takeuchi Department of Ophthalmology,   National Defense Medical College,   tokorozawa City, saitama, JapanAim:  The aim of this report was to present a case of varicella zoster virus (VZV)-associated  anterior uveitis, which developed in an adult who was seronegative for anti-VZV antibodies.",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/opth-9-399.PMC4348141.pdf
"Intraocular pressure (IOP) was 30 mmHg in the right eye Correspondence: Masaru takeuchi  Department of Ophthalmology, National  Defense Medical College,   3-2 Namiki, tokorozawa City,   saitama, 359-8513, Japan tel +81 4 2992 1511 Fax +81 4 2995 5332 email masatake@ndmc.ac.j pJournal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Mine et al Running head recto: Virus-associated uveitis with no history of chickenpox DOI: http://dx.doi.org/10.2147/OPTH.S77844",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/opth-9-399.PMC4348141.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/1f/ce/opth-9-399.PMC4348141.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1f/ce/opth-9-399.PMC4348141.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3c/2e/ndt-11-471.PMC4348142.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 471–475Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  471ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7995 0Effect of stent-assisted angioplasty on cognitive  status and serum levels of amyloid beta in patients  with intracranial and/or extracranial artery  stenosis Liandong Zhao1 Ying Zhao1 Haijun Zhang2 1Department of Neurology, The  Second People’s Hospital of Huai’an  and The Affiliated Huai’an Hospital  of Xuzhou Medical College, Huai’an,   Jiangsu, 2Department of Oncology,   Zhongda Hospital, Medical School,   Southeast University, Nanjing, People’s  Republic of ChinaAim:  The study reported here aimed to examine how stent-assisted angioplasty affects cognitive  status and serum levels of amyloid betas (A βs) 1-40 and 1-42 in patients with cerebral arterial  stenosis.",Non-OADS,/arxiv_data1/oa_pdf/3c/2e/ndt-11-471.PMC4348142.pdf
"The contribution of A β deposition in the pathogenesis  of AD has been well established and A β appears to have a role in ischemic cerebral  damage.4 Studies have suggested that plasma or serum concentrations of A β1-40 and  Aβ1-42, as well as well as the ratio of A β1-40 to A β1-42, may be used as biomarkers  for AD and dementia.5–10 For example, increased plasma A β1-40 levels are associated Correspondence: Haijun Zhang Department of Oncology,  Zhongda Hospital, Medical School,  Southeast University, 87 Dingjiaqiao,  Nanjing 210009, People’s Republic of  China Tel +86 25 8327 5418 Fax +86 25 8327 5418 Email zhanghaijunseu@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 11 Running head verso: Zhao et al Running head recto: Effect of stent-assisted angioplasty on cognitive status and A β DOI: http://dx.doi.org/10.2147/NDT.S79950",Non-OADS,/arxiv_data1/oa_pdf/3c/2e/ndt-11-471.PMC4348142.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3c/2e/ndt-11-471.PMC4348142.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/2e/ndt-11-471.PMC4348142.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 493–506Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  493OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7783 8Korean Medication algorithm Project for Bipolar  Disorder: third revision Y oung sup Woo1 Jung goo lee2,3 Jong-hyun Jeong1 Moon-Doo Kim4 inki sohn5 se-hoon shim6 Duk-in Jon7 Jeong seok seo8 Y oung-chul shin9 Kyung Joon Min10 Bo-hyun Y oon11 Won-Myong Bahk1 1Department of Psychiatry, college of  Medicine, The catholic University of  Korea, seoul, south Korea; 2Department  of Psychiatry, inje University haeundae  Paik hospital, Busan, south Korea;3Paik  institute for clinical research, inje  Univeristy, Busan, south Korea;   4Department of Psychiatry, Jeju National  University hospital, Jeju, south Korea;   5Department of Psychiatry, Keyo  hospital, Keyo Medical Foundation,   Uiwang, south Korea; 6Department of  Psychiatry, soonchunhyang University  cheonan hospital, soonchunhyang  University, cheonan, south Korea;   7Department of Psychiatry, sacred heart  hospital, hallym University, anyang,   south Korea; 8Department of Psychiatry,   school of Medicine, Konkuk University,   chungju, south Korea; 9Department of  Psychiatry, Kangbuk samsung hospital,   school of Medicine, sungkyunkwan  University, seoul, south Korea;   10Department of Psychiatry, college  of Medicine, chung-ang University,   seoul, south Korea; 11Department of  Psychiatry, Naju National hospital,   Naju,  south KoreaObjective:  To constitute the third revision of the guidelines for the treatment of bipolar  disorder issued by the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP  2014).",Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
"For example, the Korean Medication  Algorithm Project for Bipolar Disorder (KMAP-BP) began in 2001, and the first set  of guidelines, KMAP-BP 2002, was published 1 year later.16 Feasibility studies of the  KMAP-BP 2002 showed that its algorithm could be successfully implemented in clinical  settings in Korea.17–19 And based on continuing progress in psychopharmacology, the  KMAP-BP was further revised in 200620 and 2010.21correspondence: Won-Myong Bahk Department of Psychiatry, Yeouido   st Mary’s hospital, college of Medicine,   The catholic University of Korea, 10, 63-ro, Youngdeungpo-gu, seoul,   150-713, south Korea Tel +82 2 3779 1250 Fax +82 2 780 6577 email wmbahk@catholic.ac.k r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Woo et al Running head recto: Korean Medication Algorithm 2014 DOI: http://dx.doi.org/10.2147/NDT.S77838",Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
"For a certificate, please see: http://www.textcheck.",Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/dd/ndt-11-493.PMC4348143.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/prom-6-061.PMC4348144.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2015:6 61–73Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  61Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S5408 7Stroke warning campaigns: delivering better  patient outcomes?,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/prom-6-061.PMC4348144.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/ee/c9/prom-6-061.PMC4348144.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/prom-6-061.PMC4348144.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ppa-9-337.PMC4348145.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 337–345Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  337OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7937 3Patients’ experiences of living with c Ancer- associated thrombosis: the Pelic An study simon noble hayley Prout Annmarie nelson Marie curie Palliative care research  centre, cardiff University, cardiff,   Wales, UKIntroduction:  Thrombosis remains the most common preventable cause of mortality in cancer  patients receiving chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ppa-9-337.PMC4348145.pdf
"In addition to acute and long-term morbidity, CAT remains the number one cause  of death during chemotherapy and the most common cause of all cancer deaths sec - ond only to disease progression.5,6 The challenges of managing CAT are also well  recognized; cancer patients are at greater risk of both recurrent VTE and bleeding  complications compared to those without malignancy.6–8 Clinical guidelines recommend that the first-line treatment of CAT require 3–6 months  anticoagulation with weight-adjusted low-molecular-weight heparin (LMWH).9–11 Despite correspondence: simon noble Marie curie Palliative care research  Centre, 1st floor, Neuadd Meirionnydd,  cardiff University, heath Park campus,  cardiff Wales, UK Tel +44 29 2068 7500 Fax +44 29 2068 7501 email simon.noble@wales.nhs.u k Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Noble et al Running head recto: The PELICAN study DOI: http://dx.doi.org/10.2147/PPA.S79373",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ppa-9-337.PMC4348145.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f8/ba/ppa-9-337.PMC4348145.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Binding potentials of [11C]yohimbine in brain J-A Phan et al 511 © 2015 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2015), 501 –511",Non-OADS,/arxiv_data1/oa_pdf/10/13/jcbfm2014225a.PMC4348393.pdf
Statistical Analysis Statistical analysis was performed using R 3.0.2 (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/7d/ab/jcbfm2014229a.PMC4348395.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Cerebrovascular impedance in mouse CK Macgowan et al 526 Journal of Cerebral Blood Flow & Metabolism (2015), 521 –526 © 2015 ISCBFM",Non-OADS,/arxiv_data1/oa_pdf/7d/ab/jcbfm2014229a.PMC4348395.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659",OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"Selected baseline patient characteristics for the two study groups NSCLC group Control group Characteristics (N /C30109) (N /C30110) Number (%) Age 45 /C188 21 /C190 Median 66 65Gender Male 56 (51.4) 64 (58.2)Female 53 (48.6) 46 (41.8) Stage IIIa 28 (25.7)IIIb 20 (18.3)IV 61 (56.0)Exosomal proteins as potential lung cancer markers Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659",OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"*p B0.05; ***p B0.001; ****p B0.0001; ns /C30not signiﬁcant.Exosomal proteins as potential lung cancer markers Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659",OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"4.Exosomal proteins as potential lung cancer markers Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
Available from: http://www.ancr.nu 4.,Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"2004;429:101 /C17, doi: http://dx.doi.org/10.1038/429101a 15.",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"2002;2:569 /C179, doi: http://dx.doi.org/10.1038/nri855 19.",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659",OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"2014;94:107 /C116, doi: http://dx.doi.org/10.1038/labinvest.2013.130 47.",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"2014;96:214 /C123, doi: http://dx.doi.org/10.1038/clpt.2014.74 48.",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"EGFRvIII gene rearrangement is an earlyevent in glioblastoma tumorigenesis and expression deﬁnesExosomal proteins as potential lung cancer markers Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2015, 4: 26659 - http://dx.doi.org/10.3402/jev.v4.26659",OADS,/arxiv_data1/oa_pdf/c6/ef/JEV-4-26659.PMC4348413.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
Expression of some of these proteins is altered in mouseContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.02.002 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1016/0092-8674(93)90585-E 8458085 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1038/ng0893-393 8401588 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1002/mds.24024 22173986 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.2217/fnl.11.65 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1126/science.1072613 11988536 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"Parkhurst, N. Tanese, D. Krainc, Transcrip- tional repression of PGC-1alpha by mutant huntingtin leads to mitochondrialdysfunction and neurodegeneration, Cell 127 (1) (2006) 59 –69.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1093/hmg/dds516 23223017 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1371/journal.pone.0077023 24146952 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1093/ brain/114.4.1953 1832073 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1039/ ct8946500899 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/S1474-4422(14)70117-6 25231526 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"[14] C. Peers, J.P. Boyle, Oxidative modulation of K( þ) channels in the central nervous system in neurodegenerative diseases and aging, Antioxidants & Re-dox Signaling (2014) , http://dx.doi.org/10.1089/ars.2014.6007 25333910 .",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.febslet.2013.06.007 23773928 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1152/physrev.00008.2013 24137020 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.3233/JHD-120029 25063332 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"[18] A. Fredriksson, N. Schröder, P. Eriksson, I. Izquierdo, T. Archer, Neonatal iron exposure induces neurobehavioral dysfunctions in adult mice, Toxicology andApplied Pharmacology 159 (1) (1999) 25 –30.http://dx.doi.org/10.1006/ taap.1999.8711 10448122 .",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.ex- pneurol.2005.07.017 16122736 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.neurobiolaging.2006.04.003 16765489 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.nut.2010.11.007 21454054 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1371/journal.pone.0000334 17396163 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1016/j.jinorgbio.2006.02.010 16574231 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1039/c3mt00227f 24132241 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.4196-13.2014 24899723 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1093/hmg/ddg169 12812983 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"Hersch, The mTOR kinase inhibitor everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2mouse model of Huntington ’s disease, Molecular Neurodegeneration 5 (2010) 26.http://dx.doi.org/10.1186/1750-1326-5-26 20569486 .",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1523/JNEUR- OSCI.0590-05.2005 15843620 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"Fox, Characterization of striatal neuronal loss and atrophy in the R6/2 mouse model of Huntington ’s disease, PLoS Currents (2014) , http://dx.doi.org/10.1371/currents.",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/S0092- 8674(00)80514-0 9267034 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.cell.2010.08.014 20817278 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.15252/ embr.201338064 24867889 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
"Johnson, Perinatal iron de ﬁciency and neurocognitive development, Frontiers in Human Neuroscience 7 (2013) 585. http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1542/peds.2008-1047 19336381 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1096/fj.07-9574LSF 17942826 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.neuro.2007.01.014 17368774 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1038/nature02998 15483602 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2012.09.004 22982598 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1212/ WNL.43.12.2689 8255479 .,Non-OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/ 10.1016/S1353-8020(00)00028-6 11248590 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
http://dx.doi.org/10.1016/j.jada.2004.03.022 15175592 .,OADS,/arxiv_data1/oa_pdf/ea/4c/main.PMC4348428.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
394Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.02.001 2213-2317/ &2015 The Author.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nature12426 24067713 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Murphy, How mitochondria produce reactive oxygen species, Bio- chemical Journal 417 (1) (2009) 1 –13.http://dx.doi.org/10.1042/BJ20081386 19061483 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.plaphy.2010.08.016 20870416 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.redox.2013.12.011 24455476 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.pbi.2004.03.007 15134745 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nature09486 20962839 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.tibs.2013.09.001 24120033 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.yjmcc.2012.09.002 22982369 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/R.J.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Nicholls, Mitochondrial ion circuits, Essays in Biochemistry 47 (2010) 25–35.http://dx.doi.org/10.1042/bse0470025 20533898 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.redox.2014.07.003 25184115 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1073/ pnas.0604567103 17050691 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bba- bio.2014.04.005 24769119 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bba- bio.2010.04.004 20398623 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1073/ pnas.1011099107 20847295 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Willmore, S-glutathionylation reactions in mitochondrial function and disease, Frontiers in Cell and Developmental Biology 2 (2014) 68.http://dx.doi.org/10.3389/fcell.2014.00068 25453035 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1042/ BJ20110162 21726199 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.tem.2012.04.004 22591987 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Robertson, Target-based selection ofﬂavonoids for neurodegenerative disorders, Trends in Pharmacological Sciences 33 (11) (2012) 602 – 610. http://dx.doi.org/10.1016/j.tips.2012.08.002 22980637 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2011.06.022 21762777 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1089/ars.2011.4289 21954972 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.M407715200 15317809 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2012.08.015 22940066 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/ j.redox.2013.04.005 24024165 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"O ’Brien, H 2S cytotoxicity mechanism in- volves reactive oxygen species formation and mitochondrial depolarisation,Toxicology 203 (1 –3) (2004) 69 –76.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1074/jbc.M113.545301 24515115 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.09.008 24056031 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bba- bio.2013.06.005 23800966 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nature13909 25383517 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.M112.397828 23124204 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.04.006 23583329 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1164/rccm.201207-1294OC 23328522 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.ajhg.2013.06.015 23910460 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1111/j.1749- 6632.1999.tb07867.x 10672279 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1523/JNEUROSCI.1899-04.2004 15356189 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"[52] L. Bleier, I. Wittig, H. Heide, M. Steger, U. Brandt, S. Dröse, Generator-speci ﬁc targets of mitochondrial reactive oxygen species, Free Radical Biology and Medicine 78 (2015) 1 –10.http://dx.doi.org/10.1016/j.free- radbiomed.2014.10.511 25451644 .",OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1073/ pnas.0511154103 16477035 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1128/MCB.00573-12 22586278 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/ 0014-5793(80)80572-2 6998729 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/S0197-0186 (99)00114-X 10676873 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Beard, Detailed kinetics and regulation of mammalian 2-oxoglutarate dehydrogenase, BMC Biochemistry 12 (2011) 53. http://dx.doi.org/10.1186/1471-2091-12-53 21943256 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1006/abbi.1996.0560 8954577 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/tx025615j 12641442 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1515/bchm2.1983.364.2.977 6629333 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/bi027370f 12680778 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/ja1083046 21049943 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/bi971958i 9425076 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1073/ pnas.96.12.6689 10359773 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1089/ARS.2008.2291 19119916 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.R113.461368 23861399 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.03.020 23567190 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Lillig, L. Flohé, Redox regulation by glutathione needs en- zymes, Frontiers in Pharmacology 5 (2014) 168. http://dx.doi.org/10.3389/ fphar.2014.00168 25100998 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/bi4016633 24673564 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1093/bioin- formatics/btu301 24790154 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1021/bi801805h 19119849 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1016/j.biocel.2009.03.013 19467914 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Donald, J. Yu, W.W. Lin, Z. Liu, G. Steel, C. Obie, D. Valle, J. M. Phang, Overexpression of proline oxidase induces proline-dependent andmitochondria-mediated apoptosis, Molecular and Cellular Biochemistry 295(1–2) (2007) 85 –92.http://dx.doi.org/10.1007/s11010-006-9276-6 16874462 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bbabio.2013.08.007 23999537 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1038/38525 9305847 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bbabio.2012.12.002 23269318 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bbabio.2008.04.037 18501698 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nrc3803 25342630 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Skulachev, A.A. Starkov, High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria, FEBS Letters 416 (1) (1997) 15 –18.http://dx.doi.org/10.1016/S0014-5793(97) 01159-9 9369223 .",OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1146/annurev.nutr.28.061807.155357 18407744 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1152/physiol.00046.2010 21670165 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1042/BJ20110571 21554247 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/jbc.M706129200 17761668 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1093/cvr/cvn323 19050010 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Brand, Stimulation of mitochondrial proton conductance by hydroxynonenal requires a high membrane potential, Bioscience Reports 28 (2) (2008) 83 –88.http://dx.doi.org/10.1042/ BSR20080002 18384278 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bba- pap.2014.02.006 24561273 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1074/ jbc.M114.550574 24727547 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.yjmcc.2007.08.021 18076901 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1089/ARS.2009.2489 19290777 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/ nm.3212 23708290 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1007/s10863-009-9215-9 19347572 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1007/s10863-009-9211-0 19353253 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1161/ JAHA.113.000433 24275630 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.bba- bio.2012.10.016 23142169 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1681/ASN.2010050481 21803970 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.tem.2012.06.008 22831852 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1113/jphy- siol.2003.049478 14561818 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1042/BST0391221 21936793 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1007/s10541-005-0104-5 15807662 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2010.01.028 20116425 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/0003-2697(85)90381-1 4014672 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1080/10715760903062895 19562601 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1096/fj.14-261982 25351989 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1002/chem.200600522 17136791 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.2217/14796678.4.6.551 19649173 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/ 10.1038/cr.2011.81 21556035 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"[129] S. Pouvreau, Superoxide ﬂashes in mouse skeletal muscle are produced by discrete arrays of active mitochondria operating coherently, PLoS One 5 (9)(2010) , http://dx.doi.org/10.1371/journal.pone.0013035 20927399 .",Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.tcb.2012.07.007 22917552 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1146/annurev.micro.57.030502.090938 14527285 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nature13858 25341790 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1042/BJ20110883 21631430 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1126/sci- signal.2002943 22416275 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1007/978-1- 60761-756-3_16 20700717 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1038/nprot.2012.035 22517261 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1111/acel.12212 24621297 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Murphy, V. Darley-Usmar, Mitochondrially targeted compounds and their impact on cellular bioener-getics, Redox Biology 1 (1) (2013) 86 –93.http://dx.doi.org/10.1016/j.re- dox.2012.11.009 23667828 .",OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.cmet.2011.10.010 22100409 .,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1073/ pnas.96.11.6161 10339558 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1371/journal.pone.0014564 21283738 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
"Belousov, Red ﬂuorescent genetically encoded indicator for intracellular hydrogen peroxide, Nature Communications 5 (2014) 5222. http://dx.doi.org/10.1038/ncomms6222 25330925 .",OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1042/ BJ20111770 22050124 .,Non-OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2011.08.035 21964034 .R.J.,OADS,/arxiv_data1/oa_pdf/ec/21/main.PMC4348434.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
Materials and methods Animals and diet Experiments involving isolated mitochondria were performed with samples prepared from 6 weeks old female Swiss mice.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.02.003 2213-2317/ &2015 The Authors.,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
"[2] W. Dröge, Free radicals in the physiological control of cell function,Physiological Reviews 82 (1) (2002) 47 –95.http://dx.doi.org/10.1152/phys- rev.00018.2001 11773609 .",Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1073/ pnas.95.20.11715 9751731 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1038/ nrm2240 17700625 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
"Sohal, R. Weindruch, Oxidative stress, caloric restriction, and aging, Sci- ence 273 (5271) (1996) 59 –63.http://dx.doi.org/10.1126/science.273.5271.59 8658196 .",Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.tins.2004.07.005 15374670 .,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.cell.2005.02.001 15734681 .,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1113/jphy- siol.2003.049478 14561818 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.tips.2006.10.005 17056127 .,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
"Murphy, How mitochondria produce reactive oxygen species, Biochem- ical Journal 417 (1) (2009) 1 –13.http://dx.doi.org/10.1042/BJ20081386 19061483 .",OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1007/ 978-1-59745-521-3_11 19513674 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1371/ journal.pone.0077088 24116206 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2009.02.008 19245829 .,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1126/ scisignal.2003252 23281369 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1073/ pnas.95.12.6803 9618493 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.bbrc.2004.11.105 15607740 .,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
"[22] D. Pessayre, A. Berson, B. Fromenty, A. Mansouri, Mitochondria in steatohe- patitis, Seminars in Liver Disease 21 (1) (2001) 57 –69.http://dx.doi.org/ 10.1055/s-2001-12929 11296697 .",Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1093/toxsci/65.2.166 11812920 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
"[25] N. Kaludercic, J. Mialet-Perez, N. Paolocci, A. Parini, F. Di Lisa, Monoamine oxidases as sources of oxidants in the heart, Journal of Molecular and Cellular Cardiology 73 (2014) 34 –42.http://dx.doi.org/10.1016/j.yjmcc.2013.12.032 24412580 .",Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1046/j.1432- 1033.2003.03948.x 14728675 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1074/jbc.M709135200 18227065 .,Non-OADS,/arxiv_data1/oa_pdf/86/92/main.PMC4348436.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.007,OADS,/arxiv_data1/oa_pdf/b5/af/main.PMC4348441.pdf
< http://www.vlfeat.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/b5/af/main.PMC4348441.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.01.002 2049-0801/ ©2015 Published by Elsevier Ltd on behalf of Surgical Associates Ltd.,Non-OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Annals of Medicine and Surgery 4 (2015) 64 e66,Non-OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
ANZ J Surg 2006;76:668 e70.http://dx.doi.org/10.1111/j.1445-2197.2006.03797.x .,OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
J Bone Jt Surg Am 2005;87:2541 e5.http://dx.doi.org/ 10.2106/JBJS.D.03044 .,OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
http://dx.doi.org/10.1097/00005373-199701000- 00022 .,Non-OADS,/arxiv_data1/oa_pdf/de/48/main.PMC4348442.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.005,OADS,/arxiv_data1/oa_pdf/3f/d6/main.PMC4348443.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.003,OADS,/arxiv_data1/oa_pdf/52/89/main.PMC4348444.pdf
http://dx.doi.org/10.1016/j.jare.2013.11.004,OADS,/arxiv_data1/oa_pdf/ce/15/main.PMC4348445.pdf
"The primer pair for dhnandwcor genes was de- signed by PRIMER 3 program ( http://fokker.wi.mit.edu/pri- mer3/input.htm ) and was checked by OligoAnalyzer 3.1, while the primer pair for dreb gene was designed according to the sequence of Triticum aesitivum dreb gene ( wdreb ) avail- able in the NCBI database under the accession number AB193608 ( Table 1 )[22].",OADS,/arxiv_data1/oa_pdf/ce/15/main.PMC4348445.pdf
"Ltd. http://www.gatc-biotech.com/ en/home.html , ORF was found by Six-frame translation, http://www.bioline.com/calculator/01_13 .",Non-OADS,/arxiv_data1/oa_pdf/ce/15/main.PMC4348445.pdf
"DNA alignment was done by multalin ( http://bioinfo.geno- toul.fr/multalin/multalin.html ).Statistical analysis The experimental design exhibited that water regimes were in main plots, and wheat genotypes in sub plots with three ran-dom replications of two experiments.",OADS,/arxiv_data1/oa_pdf/ce/15/main.PMC4348445.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.008,OADS,/arxiv_data1/oa_pdf/83/af/main.PMC4348446.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.002,OADS,/arxiv_data1/oa_pdf/4f/6d/main.PMC4348447.pdf
This is an open access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/59/main.PMC4348448.pdf
"Speci ﬁc IgE by Fluoro Enzyme ImmunoAssay (ImmunoCAP, Thermo-scienti ﬁc, Sweden) to the different species and allergens gave the following results (kU/L): A. alternata , 3.7;Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.02.003 2211-7539/ &2015 The Authors.",OADS,/arxiv_data1/oa_pdf/74/59/main.PMC4348448.pdf
This is an open access article under the CC BY-NC-SA l icense (http://creativecommons.org/licenses/by-nc-sa/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/74/59/main.PMC4348448.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.001,OADS,/arxiv_data1/oa_pdf/ca/1a/main.PMC4348449.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4348450.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2015.01.004 2049-0801/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4348450.pdf
"Available from:, http://www.ncepod.org.uk/2007report1/ Downloads/EA_report.pdf .",OADS,/arxiv_data1/oa_pdf/83/86/main.PMC4348450.pdf
http://dx.doi.org/10.1016/j.jare.2013.12.006,OADS,/arxiv_data1/oa_pdf/e0/f8/main.PMC4348451.pdf
Initial magnetic resonance imaging (MRI) of the lumbar spine showed spondylodiscitis of vertebral bodies and intervertebralContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.02.001 2211-7539/ &2015 Published by Elsevier B.V. on behalf of International Society for Human and Animal Mycology nCorresponding author.,Non-OADS,/arxiv_data1/oa_pdf/09/97/main.PMC4348452.pdf
"Identi ﬁcation was con ﬁrmed by sequencing of the ITS2 region of the ribosomal DNA with primers ITS3 and ITS4 [7]and sequence comparison to the yeast reference database at the Cen- traalbureau voor Schimmelcultures (CBS) Fungal Biodiversity Centre (Utrecht, Netherlands) according to Clinical Laboratory Standards Institute guideline MM18-A, ( http://www.cbs.knaw.nl ).",OADS,/arxiv_data1/oa_pdf/09/97/main.PMC4348452.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/7d/main.PMC4348453.pdf
Histologic examination showed the allergicContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.02.004 2211-7539/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/54/7d/main.PMC4348453.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/7d/main.PMC4348453.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/aa/main.PMC4348454.pdf
The patient referred a previous history ( previous to the transplantation) of agricultural activities with frequent skin injuries.Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2015.01.004 2211-7539/ &2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/aa/main.PMC4348454.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f1/aa/main.PMC4348454.pdf
"He had a past medical history of insulin dependent type two diabetes, chronicContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/mmcrMedical Mycology Case Reports http://dx.doi.org/10.1016/j.mmcr.2014.12.002 2211-7539/ &2015 International Society for Human and Animal Mycology.",Non-OADS,/arxiv_data1/oa_pdf/cf/45/main.PMC4348455.pdf
Avaliable from: 〈http://emedicine.medscape.com/arti cle/227586-overview 〉(Updated 08.12.11).,Non-OADS,/arxiv_data1/oa_pdf/cf/45/main.PMC4348455.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.006,OADS,/arxiv_data1/oa_pdf/38/b3/main.PMC4348456.pdf
"Production and hosting by ElsevierJournal of Advanced Research (2015) 6, 123 –132 Cairo University Journal of Advanced Research http://dx.doi.org/10.1016/j.jare.2013.10.001 2090-1232 ª2013 Production and hosting by Elsevier B.V. on behalf of Cairo University.",Non-OADS,/arxiv_data1/oa_pdf/e0/6e/main.PMC4348457.pdf
38. http://dx.doi.org/10.1117/12.448264 [13.11.01].,Non-OADS,/arxiv_data1/oa_pdf/e0/6e/main.PMC4348457.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.003,OADS,/arxiv_data1/oa_pdf/6c/1b/main.PMC4348458.pdf
< http://ignis.usc.edu/ USC_Mech_II.htm/ >.,Non-OADS,/arxiv_data1/oa_pdf/6c/1b/main.PMC4348458.pdf
http://dx.doi.org/10.1016/j.jare.2013.07.006,OADS,/arxiv_data1/oa_pdf/21/16/main.PMC4348459.pdf
[5]http://vikno.eu/eng/health/health/scientists-develop-synthetic- hydrogel.html .,Non-OADS,/arxiv_data1/oa_pdf/21/16/main.PMC4348459.pdf
http://dx.doi.org/10.1016/j.jare.2014.01.004,OADS,/arxiv_data1/oa_pdf/c5/46/main.PMC4348476.pdf
J Chem 2013. http://dx.doi.org/10.1155/2013/254347 .,OADS,/arxiv_data1/oa_pdf/c5/46/main.PMC4348476.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
"At high concentrations, MCZ causes necroticContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinphsResults in Pharma Sciences http://dx.doi.org/10.1016/j.rinphs.2014.09.003 2211-2863/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
http://dx.doi.org/10.1248/yakushi.124.341 .15170069 .,Non-OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
http://dx.doi.org/10.3904/kjim.2010.25.2.154 .,OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
http://dx.doi.org/10.1016/ j.ijpharm.2012.06.023 .22750948 .,OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
http://dx.doi.org/10.1016/j.ijpharm.2013.02.047 .23467081 .,OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
http://dx.doi.org/ 10.1016/j.physbeh.2005.06.022 .16112152 .,OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
International Journal of Pharmaceutics 2014;464:75 –84.http://dx.doi.org/10.1016/j.ijpharm.2013.12.051 .24445120 .,Non-OADS,/arxiv_data1/oa_pdf/68/9f/main.PMC4348512.pdf
